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Introduction 
Peripheral arterial disease (PAD) shows a prevalence of 20-25% in the population 
over 65 years of age and encompasses two major clinical burdens: 1) limb ischemia and risk 
of amputation, and 2) systemic vascular dysfunction and involvement of other vascular beds 
that pertains cardiovascular complications, such as myocardial infarction and stroke which 
are the cause for death in 75% of PAD patients.  
Due to limb or life threatening sequelae of PAD, optimizing treatment in terms of both 
minimal invasiveness as well as maximizing its effects is warranted.  
The following summary encompasses original papers focusing on the treatment of 
PAD with intermittent pneumatic compression and surgical and endovascular infrainguinal 
revascularization with respect to local and systemic vascular dysfunction.  
 
Intermittent Pneumatic Compression in Patients with Infrainguinal Bypass Grafting1, 2 
Intermittent pneumatic compression (IPC) to the lower limb has been shown to 
augment native infrainguinal arterial inflow as well as skin perfusion in patients with non-
critical limb ischemia. Furthermore, it has been reported that long-term IPC application 
improves absolute walking distance compared to best medical treatment alone. In patients 
with impaired wound healing due to limb ischemia and no further revascularization options, 
significant reduction in amputation rate through IPC has been demonstrated. Whereas the 
previous studies IPC was used in non-revascularized PAD patients, we investigated the 
immediate flow enhancing effects of IPC in limbs with infrainguinal bypass grafts. 
IPC was delivered at maximum inflation and deflation pressures of 120 mm Hg and 0 
mm Hg, respectively; inflation and deflation times of 4 and 16 seconds, respectively; and a 
proximal inflate delay of 1 second (foot/calf compression preceding that of calf/thigh).  As 
assessed by ultrasound, its effect ranged from 50 per cent to 400 per cent lower limb arterial 
inflow augmentation compared to resting flow and its increase depended on localization of 
pressure application (foot, calf or thigh) and on vascular integrity (in comparison to healthy 
controls and arteriopaths without revascularization). Highest flow augmentation was found in 
healthy controls followed by grafted patients and was lowest in non-revascularized 
arteriopaths.  
The results of these two studies have important clinical implications in grafted limbs 
when an increase in graft flow is required: a) Prevention of graft failures in low-output cardiac 
conditions, b) contraindication to anticoagulation, and c) during the peripheral vascular 
readjustment in late postoperative phase that often results in an increase in peripheral 
resistance. The paucity of conservative methods available for lower limb blood flow 
augmentation may allow IPC of the lower limb to emerge as a reliable, noninvasive 
therapeutic option, ameliorating claudication and assisting infrainguinal bypass graft flow. In 
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addition, IPC to the thigh adds to the armamentarium of currently known IPC options (foot or 
calf) promoting its applicability and efficacy.  
 
Intermittent Pneumatic Compression and Local Vascular Dysfunction3 
There are several physiological mechanisms through which IPC augments lower limb 
blood flow: a) increase in the arteriovenous pressure gradient, b) up regulation of endothelial 
nitric oxide synthases through intermittent shear stress augmentation and c) the transient 
abolishment of veno-arteriolar response (VAR). As veins empty, and for most deflation time 
(16s), venous pressure falls below 25mmHg. This then results in suspension of veno-
arteriolar and myogenic reflexes, causing peripheral resistance to fall.  
We investigated the relation between skin perfusion augmentation and integrity of 
local vascular function, the veno-arteriolar reflex (VAR). The effect of IPC on skin perfusion 
was assessed by means of laser Doppler flowmetry in control limbs and limbs of PAD.  Laser 
Doppler flowmetry was used to measure VAR as percentage changes in skin blood flow in 
vertical position compared to horizontal and for skin blood flow measurement during the 
application of IPC to the foot, the calf, or both.   
As expected, baseline VAR in controls was more pronounced with 63.8 % compared 
to PAD (31.7 %). IPC generated significantly higher skin blood flow in both groups than at 
rest, showing a higher percentage increase in controls (242 to 788 %) compared to PAD (98 
to 275 %) depending on the site of compression delivery.  There were significant correlations 
between VAR and the levels of skin blood flow augmentation for all three pressure modalities 
(r=0.58, p=0.002 for calf compression, r=0.65, p<0.0001 for foot compression and r=0.64, 
p=0.0002 for foot and calf compression).   
These findings indicate that the integrity of postural lower limb veno-arteriolar 
response correlates with the level of skin blood flow augmentation induced by intermittent 
pneumatic compression suggesting that compression transiently suspends local 
autoregulatory vasoconstriction. Furthermore, the study support previous findings that VAR is 
impaired in non-critical limb ischemia.  
 
Lower Extremity Angioplasty and Local Vascular Dysfunction4 
Veno-arteriolar reflex is the local vascular auto-regulatory mechanism to adapt to 
postural changes and has been shown to be impaired or abolished in presence of limb 
ischemia as reported in the above summarized paper. We investigated the effect of lower 
limb angioplasty on VAR in patients with stable non-critical limb ischemia excluding diabetic 
patients.    
Again, foot skin blood flow was assessed by laser Doppler flowmetry in the horizontal 
and sitting positions to determine VAR. VARs in healthy controls and in patients with mild to 
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moderate peripheral arterial disease before and after successful peripheral endovascular 
angioplasty of femoropopliteal lesions were assessed and compared.   
 In PAD, VAR was higher after angioplasty (55%) compared with VAR at baseline 
(33%). Although VAR increased after lower limb angioplasty, it remained lower than in 
healthy controls (68.4%). During the 6 months of follow-up, the ankle-brachial index and VAR 
remained unchanged in absence of restenosis, demonstrating a sustained effect on local 
vasomotor function.  
The improvement in VAR following lower limb angioplasty indicates that VAR is 
sensitive to flow derangements. Given the results from the previous studies, demonstrating 
higher arterial inflow through IPC following revascularization (bypass grafting) and the fact 
that VAR integrity determines in part skin blood flow augmentation through IPC, it might be 
concluded that combination of angioplasty and IPC might have synergistic effects in treating 
patients with severe stages of PAD. Therefore, an improved VAR could result in greater 
effects of IPC on arterial and skin blood flow, suggesting a combined treatment of 
angioplasty and IPC.  
 
Lower Extremity Angioplasty and Systemic Vascular Dysfunction5 
Besides a local vascular dysfunction, systemic vascular dysfunction in PAD has been 
reported and shown to be predictive for cardiovascular prognosis. Intermittent claudication 
leads to impaired ambulatory activity and increase in oxidative stress due muscle ischemia, 
both known to deteriorate systemic vascular function, i.e. brachial flow-mediated dilation 
(FMD) as assessed by ultrasound. In a randomized, controlled study, we tested the 
hypothesis that endovascular lower limb revascularization ameliorates FMD and lowers 
inflammatory parameters.  
Whereas FMD did not differ between treatment and control group at baseline, it 
significantly improved after revascularization in the angioplasty group (6.44 ± 2.88%; 
p=0.02). In contrast, FMD in the control group was 4.53 ± 3.17% (p=0.92) at 4 weeks of 
follow up. In the angioplasty group, there was a significant decrease in leukocyte count after 
angioplasty (from 7.6 ± 2.26 x106/ml to 6.89 ± 1.35 x106/ml, p= 0.03) whereas in the control 
group leukocyte count did not differ significantly compared to baseline (7.76 ± 2.64 x106/ml, p 
= 0.94).   
This shows that lower limb revascularization might have beneficial effects beyond the 
sole relief of symptomatic claudication and that the abolishment of repeated muscle ischemia 
and/ or re-establishment of walking capacity could have beneficial effects in addition to best 
medical treatment. Yet it remains to be determined whether supervised walking exercise 
yields the same benefit as angioplasty, or rather a combination of angioplasty and 
supervised exercise training optimizes outcome.  
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The summarized papers report for the first time the extended use of application of 
IPC in grafted arteriopaths. In addition, novel insights into local and systemic vascular 
mechanisms in the treatment of peripheral arterial disease with intermittent pneumatic 
compression and angioplasty are described. These findings have implications in terms of 
both local and systemic sequelae of this disease. They offer rational for further investigations 
with combined treatment with angioplasty and intermittent pneumatic compression in the 
management of ischemic tissue lesions. Moreover, it may shift our understanding from lower 
limb angioplasty as a sole symptom relief therapy to effects that are beyond and might 
impact cardiovascular risk in PAD patients. 
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188 SURGERY
THE APPLICATION OF intermittent pneumatic com-
pression (IPC) of the lower limb generates a sig-
nificant increase in the native arterial calf inflow of
patients with peripheral vascular disease.1-3 The
long-term application of IPC of the lower limb has
been reported to enhance the walking ability of
claudicants and improve the associated hemody-
namic compromise.4 The concept of improving
Effects of intermittent pneumatic 
compression of the calf and thigh on
arterial calf inflow: A study of normals,
claudicants, and grafted arteriopaths
Konstantinos T. Delis, MD, PhD, Marc J. W. Husmann, MD, Nick J. Cheshire, MD, FRCS, and Andrew
N. Nicolaides, MS, FRCS, London, United Kingdom
Background. Recent data indicate that intermittent pneumatic compression (IPC) of the foot may offer
benefits in patients with intermittent claudication exceeding those of standard medications approved by
the Food and Drug Administration. IPC of the foot (IPCfoot) and calf (IPCcalf) increases flow velocity in
infrainguinal arterial bypass grafts and thus may prevent arterial thrombosis. Our aim was to evaluate
the acute effects of IPC of the thigh (IPCthigh), IPCcalf , and IPC of the thigh and calf (IPCcalf + thigh) in
healthy controls, claudicants, and arteriopaths who have undergone infrainguinal bypass grafting for
critical or subcritical limb ischemia.
Methods. Sixteen limbs of normals (group A), 17 limbs of claudicants (group B), and 16 limbs of arte-
riopaths (group C) who had undergone infrainguinal autologous revascularization were studied. Blood
flow was measured in the limbs of normals and claudicants in the popliteal artery and in the grafts of
revascularized limbs by using duplex ultrasonography. Mean velocity (mV), peak systolic velocity, end
diastolic velocity (EDV), pulsatility index (PI), and volume flow (Q) were measured in the sitting posi-
tion at rest and within 10 seconds from the delivery of IPCthigh, IPCcalf, and IPCcalf + thigh, IPC was
delivered at maximum inflation and deflation pressures of 120 mm Hg and 0 mm Hg, respectively;
inflation and deflation times of 4 and 16 seconds, respectively; and a proximal inflate delay of 1 second
(calf compression preceding that of thigh).
Results. In all 3 groups with all IPC modes, the Q, mV, and EDV increased while PI decreased 
(P < .05). IPCthigh was less effective than IPCcalf, but still increased Q (by 114%, 57%, and 59.8% in
groups A, B, and C, respectively) and EDV, while decreasing PI in all 3 groups (P < .05). IPCcalf + thigh
was the most efficient mode, generating an increase in the median Q of 424% in controls, 229% in
claudicants, and 317% in grafted arteriopaths. The addition of IPCthigh to IPCcalf increased the mV
and Q in group A (P ≤ .044); the mV, Q, and EDV in group B (P ≤ .03), and mV and PI by 24%
and –27% in group C, respectively. 
Conclusions. IPC applied to the thigh, either alone or in combination with IPCcalf, generates native arte-
rial and infrainguinal autologous graft flow enhancement. The paucity of conservative methods avail-
able for lower limb blood flow augmentation may allow IPC of the lower limb to emerge as a reliable,
noninvasive therapeutic option, ameliorating claudication and assisting infrainguinal bypass graft
flow. IPCthigh adds to the armamentarium of currently known IPC options (foot or calf) promoting its
applicability and efficacy. (Surgery 2001;129:188-95.)
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the arterial compromise in peripheral vascular dis-
ease appeared first in the ‘30s,5 but for decades
failed clinical acceptability. Interest has resurged in
recent years.4,6
In a recently conducted evaluation of its hemo-
dynamic effects on the blood flow of infrainguinal
arterial bypass grafts performed for critical or sub-
critical limb ischemia, IPC delivered to the foot
(IPCfoot), to the calf (IPCcalf), or to both simulta-
neously (IPCfoot + calf), generated a volume flow
enhancement ranging from 77% to 236%.7 IPCfoot
+ calf increased skin blood flux of the foot in claudi-
cants2 and grafted arteriopaths.8 Potential short-
term clinical applications of IPC include preven-
tion of graft failure in the presence of attenuated
arterial graft flow velocities7 and enhancement of
calf inflow and distal lower limb skin perfusion.8
The arterial leg inflow changes generated by IPC
are predominantly caused by its action on the nat-
ural venous pumps of the lower extremities.1,9-12
However, the effects of IPC applied to the venous
pump of the thigh on lower limb arterial hemody-
namics have never been evaluated. This study com-
pares the immediate effects of IPC of the thigh
(IPCthigh), IPCcalf, and IPC applied simultaneously
to the thigh and calf (IPCcalf + thigh) on native calf
inflow in healthy volunteers and in claudicants and
on the hemodynamics of patients who have had
infrainguinal arterial bypass grafting performed
for critical or subcritical ischemia.
MATERIALS AND METHODS
Study groups. The effects of IPCthigh, IPCcalf,
and IPCcalf + thigh on lower extremity arterial hemo-
dynamics were evaluated in 16 limbs of control sub-
jects (group A), 17 limbs with intermittent claudi-
cation (group B), and 16 limbs of arteriopaths with
infrainguinal autologous bypass grafting (group
C). The demographics of the subjects included in
the study are depicted in the Table.
Selection of study subjects. Resting ankle
brachial pressure indices were determined by
dividing the higher ankle pressure (obtained
from the dorsalis pedis or the posterior tibial
arteries) by the higher of the 2 brachial artery
pressures after a 15-minute resting period in the
supine position. Post-exercise ankle-brachial pres-
sure indices were also obtained after a 1-minute
treadmill exercise test at a speed of 3.8 km/h and
a gradient of 10%. Subjects with no history of arte-
rial or venous disease, unremarkable clinical
investigation, and lower limb arterial duplex scan-
ning with resting and post-exercise indices
exceeding 1.0 were included in group A. After
Doppler pressures were determined, a graft sur-
veillance examination was conducted with color
flow duplex imaging (group C). Patients with suc-
cessful (hemodynamically uncompromised) arter-
ial grafting were recruited into the study. On
duplex ultrasound evaluation, there was neither
evidence of diameter stenosis greater than 30% in
the entire length of the graft nor stenosis in the
runoff circulation, with clean triphasic Doppler
flow velocity waveforms demonstrated at the
ankle. Group B consisted of patients with inter-
mittent claudication due to superficial femoral
artery occlusion, with ankle brachial pressure
indices of less than 0.8 at rest, decreasing further
post-exercise. Exclusion criteria for all 3 study
groups were: congestive cardiac failure, peripher-
al edema, limb-threatening ischemia, clinically
detectable diabetic neuropathy, lumbar sympa-
thectomy, deep vein thrombosis, chronic venous
insufficiency (CEAP 2-613,14 or venous reflux > 0.5
Table. Demographics of studied subjects and type of grafts
Controls (group A) Claudicants (group B) Grafts (group C) Significance
Limbs (right/left) 16 (7/9) 17 (12/5) 16 (9/7) NS
Subjects (male/female) 10 (10/0) 15 (13/2) 16 (15/1) NS
Age (range) 58 (34-75) years 64 (47-72) years 65 (44-77) years NS
ABI (interquartile range) > 1 0.68 (0.52-0.76) > 1 < .0001 (A vs B)
Post-exercise ABI > 1 0.31 (0.12-0.51) > 0.95* < .0001 (A vs B)
Time post-surgery — — 16 (5-39)
Runoff artery — — 3 popliteal above knee†
5 popliteal below knee‡
2 anterior tibial§
6 posterior tibial§
The ankle brachial indices (ABI) in claudicants are significantly lower than those of controls and grafted subjects (P < .0001). 
*Those (8/16) who could complete. 
†Procedures performed for short-distance claudication.
‡Procedures performed either for short-distance claudication (n = 2) or for critical limb ischemia (n = 3).
§Procedures performed for critical limb ischemia (4 ulcers).
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seconds), cellulitis or infected leg ulcers, and
vasoactive medication (eg, nifedipine).
Examination and scanning protocol. Lower limb
arterial blood flow was investigated with color flow
duplex (HP Sonos 2500; Palo Alto, Calif) fitted with
a 7.5/5.5 MHz linear array probe. In groups A and
B, blood flow was evaluated in the middle third of
the popliteal fossa (2 cm proximal to the medial
condyle). In grafted arteriopaths (group C), flow
was measured in the graft at knee level. Subjects in
all groups were scanned in the sitting position, with
their legs dependent, slightly extended at the knees
and their feet resting on a low stool. The thigh and
calf pads of the intermittent pneumatic compression
system were gently applied and, after a resting peri-
od of 15 minutes to allow for flow stabilization, mea-
surements were taken. 
Resting arterial blood flow was initially mea-
sured (≥ 3 estimations). One of the 3 IPC modes
(IPCthigh, IPCcalf, or IPCcalf + thigh), chosen at ran-
dom, was then applied and new flow measurements
(≥ 3) obtained, starting from the second minute of
pump action. Flow was always estimated immedi-
ately after and within 10 seconds of the delivery of
IPC. After a 10-minute resting period, during
which the pump was switched off, new resting flow
estimations (≥ 3) were obtained. The next IPC
mode, again chosen at random, was then applied
and flow measurements (≥ 3) repeated, again start-
ing from the second minute of pump action. The
same protocol was followed for the evaluation of
flow before and during the delivery of the third
IPC mode.
The internal diameter of the arterial or graft
lumen, the average of 3 to 4 estimations, was
obtained by viewing the graft longitudinally and
cross-sectionally on real-time B-mode and by using
the tracker ball-guided calipers. Spectral analysis of
pulsed Doppler signals insonating the entire
lumen allowed determination of the mean velocity
(mV). The gate of the sample volume was adjusted
to the lumen of the vessel; and the 60-degree angle
of insonation, and the site of gated Doppler sam-
pling, carefully maintained. The mV is the time
average of the mVs of each of the velocity spectra
occurring during an interval of at least 4 cardiac
cycles. The mV during a selected time, always with-
in 5 seconds of the delivery of an impulse, was cal-
culated by using software that enabled tracing of
the waveform profiles. The reproducibility of this
method has been previously evaluated.3
Volume flow was calculated from the mV multi-
plied by the cross-sectional area of the popliteal
artery or graft and was expressed in mL/min. Data
gained from automated computer-assisted analysis
of the profiles of spectral flow velocity waveforms
included the pulsatility index (PI), the peak systolic
velocity (PSV) and end diastolic velocity (EDV).
Pulsed Doppler spectral waveforms distorted by
aliasing noise caused by venous flow or wall motion
were discarded and measurements were repeated. 
Analysis of data was performed with nonpara-
metric statistics (Minitab 8.2 software package,
Minitab Inc, State College, Pa; and StatView 4.57,
Abacus Concepts, Inc, Berkley, Calif). Intragroup
data were compared by using the Wilcoxon signed
rank and Friedman tests; for intergroup statistics
the Kruskal-Wallis test was used. Data are expressed
as median and interquartile range. 
Impulse unit. All 3 types of IPC (IPCthigh, IPCcalf,
and IPCcalf + thigh) were delivered by using a mechan-
ical pneumatic pump (Art Assist 1000 unit; ACI, San
Marcos, Calif). The pump consists of a pneumatic
impulse generator and 2 inflatable plastic pads
designed to fit the calf and thigh comfortably. The 2
large bore elastic tubes connecting the unit with
each pad separately offer the versatility of isolating
each pad from the other, thus allowing use of the 3
types of IPC. The investigation was conducted with
the pump operating at the following presets: maxi-
mum inflation and minimum deflation pressures of
120 and 0 mm Hg, respectively; an inflation time of
4 seconds with a rise time of 0.3 seconds; and a rapid
deflation time of 16 seconds. On application of
IPCcalf + thigh, the onset of the calf impulse preceded
that of the thigh by 1 second (delay time).
RESULTS
In all 3 groups, a significant increase in arterial
calf inflow velocities and a decrease in the pulsatil-
ity index with all IPC modes (IPCthigh, IPCcalf, and
IPCcalf + thigh) were documented. IPCthigh generat-
ed significantly higher levels of volume flow than
that at baseline. It was, however, less effective than
IPCcalf. Concurrent application of IPCthigh added
significantly to the hemodynamic benefits generat-
ed with IPCcalf.
Mean flow velocity (mV). The mV increased on
application of IPCthigh in all study groups ( Fig 1; P
< .001). The percentage increases of the median
mV were 95% in normals (group A), 51% in clau-
dicants (group B), and 78% in grafted arteriopaths
(group C). A higher median mV was generated
with IPCcalf + thigh (365% group A, 182% group B,
385% group C) than with IPCcalf (313% group A,
137% group B, 290% group C; P = .044 for group
A; P = .034 for group B; P = .5  for group C). The
mean velocity among claudicants was higher than
that of the control and grafted subjects both at rest
and with IPC (P ≤ .016).
Surgery Delis et al 191
Volume 129, Number 2
Diameter. No significant increase was docu-
mented in the diameter of the popliteal artery with
IPCthigh, IPCcalf, or IPCcalf + thigh in groups A and B.
There was a small but consistent increase in the
graft diameter with IPCcalf + thigh (from median 0.52
cm [interquartile range, 0.50-0.65 cm] to 0.54 cm
[interquartile range, 0.50-0.66 cm] [P = .016]). The
baseline popliteal artery diameter in claudicants
(median, 0.34 cm; interquartile range, 0.28-0.41
cm) was much smaller than that in healthy limbs
(median, 0.60 cm; interquartile range, 0.50-0.63
cm; P = .001). The baseline diameter of autologous
grafts (median, 0.52 cm; interquartile range, 0.50-
0.65 cm) was greater than that of the popliteal
artery in group B (P = .008). 
Volume flow (Q). Volume flow (Q) increased
upon application of IPCthigh, IPCcalf, and IPCcalf +
thigh in groups A, B, and C (Fig 2, P ≤ .01). IPCcalf +
thigh generated the highest median volume flow in
all 3 groups. The percentage increase in the medi-
an Q with IPCthigh was 114%, 57%, and 60% in
groups A, B, and C, respectively; with IPCcalf, it was
347%, 122%, and 293% in groups A, B, and C,
respectively; with IPCcalf + thigh, it was 424%, 229%,
and 317% in groups A, B, and C, respectively.
Although differences at rest were nonsignificant,
the volume flow generated with IPC was higher
among the controls and grafted arteriopaths than
claudicants (P = .0001).
Peak systolic velocity (PSV). The peak systolic
velocity (PSV) increased upon application of
IPCthigh (P < .005), IPCcalf, and IPCcalf + thigh (in
both, P ≤ .002) in all 3 groups (Fig 3). There was no
difference in the PSV produced by IPCcalf and by
IPCcalf + thigh in all study groups. The PSV in claudi-
cants was significantly lower than that among con-
trol subjects and grafted arteriopaths both at rest
and on IPC (P ≤ .005). 
End diastolic velocity (EDV).  End diastolic
velocity (EDV) increased on application of IPCthigh
(P ≤ .02), IPCcalf and IPCcalf + thigh (both P ≤.001) in
all study groups (Fig 4). The EDVs with IPCcalf and
IPCcalf + thigh were higher than with IPCthigh (P ≤
.01). A higher median EDV was generated by
IPCcalf + thigh than with IPCcalf in all 3 groups; how-
ever, the difference was significant among claudi-
cants (P = .01) only. The EDV among claudicants
was higher than that in either control subjects or
grafted arteriopaths both at rest and with IPC 
(P ≤ .01).
Pulsatility index (PI). The pulsatility index (PI)
decreased with IPCthigh (P < .03), and IPCcalf and
IPCcalf + thigh (both P ≤ .001) (Fig 5). In all groups,
PIs with either IPCcalf or IPCcalf + thigh were lower
than with IPCthigh (P ≤ .007). There was no differ-
ence in the PIs generated by IPCcalf + thigh and
IPCcalf. The PI in group B, both at rest and with IPC
(IPCthigh, IPCcalf, and IPCcalf + thigh) was lower than
Fig 1.  Effects of IPC (IPCthigh, IPCcalf, and IPCcalf + thigh) on mean flow velocity (mV) in 16 limbs of healthy
subjects, 17 limbs of claudicants, and 16 limbs with infrainguinal bypass grafting. In all groups, IPCcalf +
thigh and IPCcalf generated higher mV than IPCthigh (P < .001), which produced a higher mV than that at
rest (P < .001). There were no intergroup differences with IPCcalf + thigh, nor with IPCcalf (P > .05). IPCthigh
produced higher mV in claudicating limbs than in healthy or revascularized limbs (P < .05). (See Results.)
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that either in group A or group C (P < .0001).
There was no difference in the PI with IPC between
groups A and C upon IPC.
DISCUSSION
This study demonstrates that IPC applied to the
thigh alone or in combination with IPCcalf is an
effective means of enhancing the arterial calf
inflow in limbs with unimpaired perfusion, inter-
mittent claudication, and successful infrainguinal
revascularization. IPCthigh increased the median
arterial calf inflow by 57% in limbs with claudica-
tion and the median graft flow in patients with
femoropopliteal and femorodistal bypass grafting
by 60%. Enhancement of the median popliteal vol-
ume flow was even greater in healthy limbs (114%).
In all groups investigated, flow enhancement was
associated with an increase in the EDV and a
decrease in the PI. The changes in these indicators
of peripheral resistance to flow15 indicate that IPC
of the thigh produces flow augmentation by atten-
uating resistance, as it does when applied to the
foot, calf, or both simultaneously.3,9
The effect of IPCcalf on the arterial calf inflow
was supplemented by the addition of IPC of the
thigh (IPCcalf + thigh), which in all groups generated
higher levels of volume flow than those produced
by IPCcalf alone. Enhancement of popliteal artery
volume flow with IPCcalf + thigh (424%, 229%, and
317% in groups A, B, and C) was higher than that
with IPCcalf (347%, 122%, and 293% in groups A,
B, and C). The superiority of IPCcalf + thigh in terms
of flow enhancement was also evident in the PI, the
median value of which was attenuated in all groups
by another 20% to 34%, and the EDV, which
increased among claudicants by 25%. It appears
that the additional benefit to flow augmentation
arising from the combination of IPCthigh and
IPCcalf is provided by further attenuation in periph-
eral resistance to flow.
Previous studies have demonstrated that IPCfoot
+ calf can produce an increase in lower limb blood
flow despite the presence of atherosclerosis.1-
3,9,10,12 The current study differs in that it shows for
the first time that IPCthigh is an alternative method
of generating arterial calf inflow enhancement in
claudicants and patients with infrainguinal arterial
grafts. It also shows that IPCthigh can be combined
with IPCcalf, promoting its beneficial effect on
peripheral flow. 
There are 3 mechanisms by which IPC of the
lower limb enhances arterial calf inflow. The first is
the only one to have been proven: IPC expels
venous blood from the leg into the thigh, reducing
Fig 2.  Effects of IPC (IPCthigh, IPCcalf, and IPCcalf + thigh) on volume flow (Q) in 16 limbs of healthy sub-
jects, in 17 limbs with claudication, and in 16 limbs with infrainguinal bypass grafting. IPCcalf + thigh, IPCcalf,
and IPCthigh increased Q in all groups (P ≤ .01). IPCcalf + thigh and IPCcalf produced higher Q than IPCthigh
(P < .001) in all study groups. There was no difference in the Q among the 3 study groups in the sitting
position, at any one of the 3 resting time points (P > .05), or on application of IPCthigh (P > .1). IPCcalf +
thigh and IPCcalf produced higher Q in controls and grafted limbs than in claudicating ones (P < .01). (See
Results.)
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venous pressure on limb dependency and resulting
in an increase of the arteriovenous pressure gradi-
ent.1,9-11 Pressure from an average of 60 mm Hg on
sitting at rest decreases to 20 mm Hg with IPCfoot,
to 14 mm Hg with IPCcalf, and to < 10 mm Hg with
IPCfoot + calf, when pneumatic compression of 120
mm Hg is applied for 4 seconds 3 times per
minute.11 Changes in the arteriovenous pressure
gradient may generate a flow increase of up to
70%.12 The second putative mechanism is the tran-
Fig 3.  Effects of IPC (IPCthigh, IPCcalf, and IPCcalf + thigh) on peak systolic velocity (PSV) in 16 limbs of
healthy subjects, in 17 limbs with claudication, and in 16 limbs with infrainguinal bypass grafting. IPCthigh,
IPCcalf, and IPCcalf + thigh enhanced PSV in all groups (P ≤ .005). IPCcalf + thigh and IPCcalf produced high-
er PSV than IPCthigh (P < .003). No difference was found between controls and grafted subjects at rest 
(P > .05). (See Results.)
Fig 4. Effects of IPC (IPCthigh, IPCcalf, and IPCcalf + thigh) on end diastolic velocity (EDV) in 16 limbs of healthy
subjects, in 17 limbs with claudication, and in 16 limbs with infrainguinal bypass grafting. IPCcalf + thigh, IPCcalf,
and IPCthigh increased EDV in all groups (P ≤ .02). EDV at rest was higher in claudicating limbs than in graft-
ed ones or controls (P < .001). There was no difference between healthy and grafted limbs either in the rest-
ing sitting position or with IPC (P > .05). (See Results.) 
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sient suppression of the veno-arteriolar response
which results from a decrease in the venous pres-
sure immediately after delivery of a pneumatic
impulse.3,9 This response is mediated by means of a
sympathetic axon reflex and results in attenuation
of the precapillary peripheral vasoconstriction.16-19
Thirdly,  it has been suggested that promotion of
the release of nitric oxide secondary to increased
shear stress with IPC may lead to additional vasodi-
latation of the arterioles and precapillaries and to
subsequent enhancement of peripheral arterial
blood flow.1-2,12,20 However, data in support of this
have yet to be presented. 
The median flow enhancement recorded in this
study within the groups of claudicants and grafted
arteriopaths did not exceed 60% with IPCthigh; how-
ever, in a few limbs in these groups, flow increases far
greater than this were recorded, exceeding 125% in
some cases. This observation, and the greater than
100% increase in blood flow among healthy sub-
jects, indicate that the only proven mechanism of
flow enhancement—the decrease in arteriovenous
pressure gradient—may be only part of the mecha-
nism of flow enhancement with IPCthigh. On appli-
cation of IPCcalf + thigh in the presence of a median
flow augmentation exceeding 230% in both controls
and arteriopaths, all of the aforementioned mecha-
nisms may be involved. 
Compression of the thigh causes maximal expul-
sion of the venous blood stored in the muscular
veins of the profunda femoris system and the
superficial femoral vein. The subsequent increase
in flow with IPCthigh would therefore be distributed
both within the profunda femoris artery system and
the superficial femoral artery with possibly greater
flow enhancement occurring in the former.
Provided that both vessels are patent, the effect of
IPCthigh would be more direct in the thigh than in
the arterial foot and calf inflow. The entire venous
capacitance of the thigh is exhausted on direct
exertion of applied pressure of 120 mm Hg,
enabling maximal arteriovenous pressure gradient
enhancement in the profunda femoris circulation,
in addition to the effects of endothelium-derived
vasodilators. On the other hand, expulsion of
venous blood from the superficial femoral vein
alone would normally be expected to reduce the
venous pressure of the dependent leg significantly,
though probably not generating the levels provid-
ed with IPCcalf or IPCfoot + calf. 
Enhancement of the arterial calf inflow with
IPCthigh offers the potential for several clinical
applications. Patients with severe peripheral vascu-
lar disease may have their calf inflow enhanced by
receiving IPCthigh when the application of IPC in
the calf or the foot is not feasible because of leg
Fig 5.  Effects of IPC (IPCthigh, IPCcalf, and IPCcalf + thigh) on pulsatility index (PI) in 16 limbs of healthy
subjects, in 17 limbs with claudication, and in 16 limbs with infrainguinal bypass grafting. IPCcalf+ thigh,
IPCcalf, and IPCthigh caused PI to decrease in all groups (P < .03). Baseline PI was lower in claudicants than
in grafted subjects (P ≤ .01), and PI in controls was higher than that in grafted limbs (P ≤ .004), at all 3
resting time points. On intragroup comparison of the PIs at the 3 resting time points, no significant dif-
ferences were found (P > .05). (See Results.)
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infection, painful skin ulcers, recently performed
surgery, unhealed wounds, dressings, or casts. IPC
of the thigh can also be applied to enable flow
enhancement additional to that generated with
IPCcalf, when IPCfoot cannot be used (foot gan-
grene, infection, ulcers, wounds, recent surgery).
Just as IPC has shown long-term efficacy in improv-
ing the walking capacity of claudicants with super-
ficial femoral artery occlusion,4 IPCthigh may
improve thigh claudication secondary to severe
profunda femoris artery disease (tandem lesions)
not amenable to profundoplasty or percutaneous
transluminal angioplasty. IPCthigh also offers an
alternative option of graft flow velocity enhance-
ment, when for causes unrelated to the graft, flow
attenuates and velocities decrease below the critical
threshold for graft patency. 
In conclusion, IPC applied to the thigh alone or
in combination with IPC of the calf, is an effective
method of native arterial and infrainguinal autolo-
gous graft flow enhancement. An increase in the
EDV and a decrease in the PI during its application
suggest that this effect may be attributable to a
decrease in peripheral resistance. In the paucity of
conservative methods available for lower limb
blood flow enhancement in peripheral vascular dis-
ease, IPCthigh with its leg inflow enhancing ability,
alongside other IPC modes, may emerge as a reli-
able, noninvasive therapeutic discipline, improving
claudication, assisting infrainguinal bypass graft
patency, and providing arterial supply in support of
wound healing. IPCthigh adds to the armamentari-
um of currently known IPC options (foot or calf),
promoting its flexibility, applicability, and efficacy. 
We thank Mary I. Kerle, BA, for her assistance in edit-
ing and Sanofi Winthrop, SA, Geneva, Switzerland, for
support.
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Original article
Haemodynamic effect of intermittent pneumatic compression
of the leg after infrainguinal arterial bypass grafting
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Background: Intermittent pneumatic compression (IPC) may increase blood flow through infrainguinal
arterial grafts, and has potential clinical application as blood flow velocity attenuation often precedes
graft failure. The present study examined the immediate effects of IPC applied to the foot (IPCfoot),
the calf (IPCcalf ) and to both simultaneously (IPCfoot+calf ) on the haemodynamics of infrainguinal bypass
grafts.
Methods: Eighteen femoropopliteal and 18 femorodistal autologous vein grafts were studied; all had
a resting ankle : brachial pressure index of 0·9 or more. Clinical examination, graft surveillance and
measurement of graft haemodynamics were conducted at rest and within 5 s of IPC in each mode using
duplex imaging. Outcome measures included peak systolic (PSV), mean (MV) and end diastolic (EDV)
velocities, pulsatility index (PI) and volume flow in the graft.
Results: All IPC modes significantly enhanced MV, PSV, EDV and volume flow in both graft
types; IPCfoot+calf was the most effective. IPCfoot+calf enhanced median volume flow, MV and PSV in
femoropopliteal grafts by 182, 236 and 49 per cent, respectively, and attenuated PI by 61 per cent.
Enhancement in femorodistal grafts was 273, 179 and 53 per cent respectively, and PI attenuation was
63 per cent.
Conclusion: IPC was effective in improving infrainguinal graft flow velocity, probably by reducing
peripheral resistance. IPC has the potential to reduce the risk of bypass graft thrombosis.
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Introduction
Intermittent pneumatic compression (IPC) of the leg
generates a significant increase in arterial blood flow in
patients with peripheral vascular disease1–3. IPC of the foot
(IPCfoot) increases arterial calf inflow by 50–90 per cent
in arteriopaths, and by more in normal subjects1,3. A
threefold to fourfold increase in the calf blood flow has
been reported with foot and calf compression (IPCfoot+calf)
in patients with superficial femoral artery occlusion2,4.
The application of IPC for over 4 months ameliorates
intermittent claudication and improves the ankle : brachial
pressure index (ABPI)5,6. This is probably due to a flow-
dependent promotion of collateral circulation5,6.
Arterial grafts are complicated by early occlusion in up to
20 per cent of distal bypasses7. Failure that occurs within
the first 2 or 3 days is usually due to poor selection or
technical error; late failure within the first month results
from a number of factors, including technical imperfection,
persistent underlying disease and surface thrombogenicity
of the graft8,9. It has been suggested that there is a critical
threshold velocity required for ensuring graft patency in
these early stages10,11. The likelihood of early thrombosis
is high in a small-calibre graft placed into a high-resistance
circulation, such as in the case of a femorodistal bypass
graft in the presence of low flow velocities.
It was hypothesized that, analogous to its beneficial effect
on native arterial blood flow, the application of IPC might
also enhance arterial blood flow through an infrainguinal
bypass graft. This might have clinical advantages, as low
flow velocity precedes graft failure12. The aim of this
study was to compare the immediate effects of IPCfoot,
IPCfoot+calf and IPC of the calf (IPCcalf ) on arterial bypass
graft haemodynamics in patients who had infrainguinal
revascularization for ischaemia.
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Patients and methods
Study groups
Graft flow velocities during IPC were measured in 16
patients with 18 femoropopliteal grafts (five above and 13
below knee) and in 18 patients with 18 femorodistal grafts
(two peroneal, nine posterior tibial, five anterior tibial
and two dorsalis pedis). There were 13 men and three
women of mean(s.d.) age 65·9(9·6) years in the former
group, and 15 men and three women aged 68·8(7·5) years
in the latter group. All grafts were autologous vein. The
femoropopliteal grafts had been inserted for a median of 17
(interquartile range 7·5–33) months and the femorodistal
grafts for a median of 18 (interquartile range 12–26)
months.
Patients who had an infrainguinal bypass were assessed
by measurement of resting ABPI followed by graft
surveillance using duplex imaging. Uncompromised grafts,
defined by a resting ABPI of 0·9 or more, and no significant
(50 per cent diameter or more) stenosis on duplex imaging,
were recruited into the study.
Study design
The sequence of IPC application was subject to a
crossover design. To eliminate bias from carry-over
effects, the two study groups, comprising 18 legs
each, had all six possible combinations of IPC sequen-
ces (IPCfoot –IPCcalf –IPCfoot+calf , IPCfoot –IPCfoot+calf –
IPCcalf , etc.) applied to their legs and investigated evenly
(three legs per sequence). These sequences were allotted
numbers 1–18 at random from sealed envelopes, one for
each new entry.
Examination and imaging protocol
Graft blood flow was studied using colour duplex
ultrasonography with a linear-array 7·5-MHz probe.
Subjects were scanned in the sitting position, with their
legs dependent, slightly extended at the knees, and their
feet resting on a low stool. Foot and calf pads enabling
IPC delivery were applied, and a resting period of 15 min
was allowed for flow stabilization, during which the subject
remained seated.
Graft blood flow was measured first at rest, and then
with IPC activated. Blood flow was studied on the sixth
minute of IPC action. Data were retrieved within 5 s of
IPC delivery and IPC was then switched off. After resting
for 10 min, blood flow was reassessed. The second IPC
mode was then engaged and flow measurement started on
the sixth minute of pump action. Similarly, blood flow was
measured before, and on delivery of the third IPC mode.
At least three readings were obtained and then the mean
was calculated. Internal diameter was obtained from longi-
tudinal and cross-sectional graft views, in both systole and
diastole on real-time B-mode imaging. Graft diameter was
measured both at rest and with IPC (initial 5 s after com-
pression). At least three measurements were made at each
time point, and the mean was calculated. Spectral analysis
of gated Doppler signals insonating the entire lumen at 60◦
enabled determination of mean velocity (MV). Positioning
of the gate of the Doppler probe was meticulously main-
tained using physical landmarks. The MV was the mean
of each of the velocity spectra occurring during an interval
of at least four cardiac cycles; MV at rest and within 5 s
of IPC was calculated with dedicated software tracing the
waveform profiles. The reproducibility of the method has
been reported previously3.
Volume flow was calculated by multiplying MV by
the cross-sectional area of the graft. Data gained from
computer-assisted analysis of the profiles of spectral
waveforms include pulsatility index (PI), and peak systolic
(PSV) and end diastolic (EDV) velocities. Doppler
waveforms containing aliasing, noise or wall motion were
discarded. All haemodynamic evaluations were obtained by
insonating grafts at the junction of the middle and distal
thirds of the thigh by the same operator.
Impulse unit
All three IPC modes were delivered with an Art Assist
1000 unit (ACI, San Diego, California, USA). This
mechanical pump consisted of a pneumatic impulse
generator and two inflatable plastic pads designed to fit the
foot and calf. Two large-bore tubes connecting the unit
with each pad separately offered the versatility of isolating
(with clamps) each pad from the other, thus enabling three
IPC modes. The pump operated at the following presets:
inflation pressure 120 mmHg, deflation pressure 0 mmHg,
and inflation and deflation times 4 and 16 s respectively.
With IPCfoot+calf , the onset of the foot impulse preceded
that of the calf by 1 s.
Statistical analysis
Data analysis was performed using non-parametric statis-
tics (Minitab 8.2; State College, Pennsylvania, USA) and
Stat-View 4·57 (Abacus Concepts, Berkeley, California,
USA). Intragroup data were compared using theWilcoxon
signed rank test. Intergroup statistics were obtained using
the Mann–Whitney U test.
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Results
Mean velocity
RestingMVwas similar in femoropopliteal and femorodis-
tal grafts (Fig. 1a). Median MV increased by 39 per cent in
femoropopliteal (P = 0·001) and 36 per cent in femorodis-
tal (P < 0·001) grafts on IPCfoot, by189 per cent in
femoropopliteal and 170 per cent in femorodistal grafts
on IPCcalf (both P < 0·001), and by 236 per cent in
femoropopliteal and 179 per cent in femorodistal grafts
on IPCfoot+calf (both P < 0·001). Increases in MV were
similar in femoropopliteal and femorodistal grafts for any
IPC mode. The MV on IPCfoot+calf was higher than
that on IPCcalf (femoropopliteal P = 0·019; femorodis-
tal P = 0·015) and IPCfoot (both groups P < 0·001). MV
on IPCcalf was higher than that on IPCfoot (both groups
P < 0·001).
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Fig. 1 Effects of intermittent pneumatic compression of the foot
and calf (IPCfoot+calf ), calf (IPCcalf ) and foot (IPCfoot) on a mean
velocity and b peak systolic velocity in 18 femoropopliteal and 18
femorodistal grafts. Values are expressed as median and
interquartile range
Diameter
Baseline graft diameter, measured at a middle to distal
thigh level, was slightly but not significantly greater
in femoropopliteal than femorodistal grafts (Table 1).
IPCfoot+calf resulted in diameter increase in both groups
(P < 0·001 and P = 0·025 respectively). The diameter
increase with IPCcalf was marked in femoropopliteal grafts
(P = 0·003).
Volume flow
Resting volume flow was similar in the two graft types
(Fig. 2a). Median volume flow increased by 76 per cent in
both femoropopliteal (P = 0·002) and femorodistal (P <
0·001) grafts on IPCfoot, by 172 per cent in femoropopliteal
and 186 per cent in femorodistal grafts on IPCcalf (both
P < 0·001), and by 182 per cent in femoropopliteal and
273 per cent in femorodistal grafts on IPCfoot+calf (both
P < 0·001). Increases in volume flow were similar in
femoropopliteal and femorodistal grafts for any IPCmode.
IPCfoot+calf generated a higher volume flow than IPCcalf
(femoropopliteal P = 0·013; femorodistal P = 0·006) and
IPCfoot (both groups P < 0·001). Volume flowwith IPCcalf
was higher than that with IPCfoot (both groups P < 0·001).
Peak systolic velocity
Baseline PSV was similar in femoropopliteal and
femorodistal grafts (Fig. 1b). Median PSV increased by
17 per cent in femoropopliteal (P = 0·13) and 18 per cent
in femorodistal (P = 0·002) grafts on IPCfoot, by 62
per cent in femoropopliteal and 45 per cent in femorodis-
tal grafts on IPCcalf (both P < 0·001), and by 49 per cent
in femoropopliteal grafts and 53 per cent in femorodistal
grafts on IPCfoot+calf (both P < 0·001). Increases in PSV
were similar in femoropopliteal and femorodistal grafts for
any IPC mode. PSV on IPCfoot+calf was similar to that on
IPCcalf . PSV on either IPCfoot+calf or IPCcalf was higher
than that on IPCfoot (both P = 0·002).
End diastolic velocity
Baseline EDV was similar in femoropopliteal and
femorodistal grafts. On IPCfoot, median EDV increased
from 0 at baseline to 2·6 cm/s in femoropopliteal grafts
and from 0 to 4·l cm/s in femorodistal grafts (both
P < 0·001). On IPCcalf , EDV increased from 0 to 7·2 cm/s
in femoropopliteal (P < 0·001) and from 0 to 8·8 cm/s in
femorodistal grafts (P = 0·001). On IPCfoot+calf , median
EDV increased from 0 to 8·3 cm/s in femoropopliteal
grafts (P < 0·001) and from 0 to 8·8 cm/s in femorodistal
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Table 1 Effect of intermittent pneumatic compression on the luminal diameter of femoropopliteal and femorodistal grafts
Femoropopliteal Femorodistal
Diameter (cm) P* Diameter (cm) P*
At rest 0·565 (0·505–0·636) — 0·492 (0·444–0·557) —
IPCfoot+calf 0·585 (0·520–0·663) <0·001 0·519 (0·448–0·593) 0·025
IPCcalf 0·578 (0·521–0·654) 0·003 0·521 (0·443–0·590) 0·330
IPCfoot 0·577 (0·511–0·656) 0·640 0·503 (0·433–0·550) 0·320
Values are median (interquartile range). Intermittent pneumatic compression was applied to the foot (IPCfoot), calf (IPCcalf ) or both combined
(IPCfoot+calf ). *Versus value at rest (Mann–Whitney U test). There were no significant differences between femoropopliteal and femorodistal graft luminal
diameters under any condition tested.
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Fig. 2 Effects of intermittent pneumatic compression of the foot
and calf (IPCfoot+calf ), calf (IPCcalf ) and foot (IPCfoot) on a volume
flow and b pulsatility index in 18 femoropopliteal and 18
femorodistal grafts. Values are expressed as median and
interquartile range
grafts (P = 0·001). Increases in EDV were similar in
femoropopliteal and femorodistal grafts for any IPCmode.
EDV on IPCfoot+calf was similar to that on IPCcalf . EDV
on IPCcalf or IPCfoot+calf was higher than that on IPCfoot
(both P = 0·002).
Pulsatility index
Baseline PI was similar in the two graft types (Fig. 2b).
Median PI on IPCfoot decreased by 24 per cent in
femoropopliteal (P = 0·040) and 21 per cent in femorodis-
tal grafts (P < 0·001). On IPCcalf , median PI decreased
by 56 per cent in femoropopliteal grafts and 57 per cent
in femorodistal grafts (both P < 0·001). On IPCfoot+calf ,
median PI decreased by 61 per cent in femoropopliteal
grafts and 63 per cent in femorodistal grafts (both P <
0·001). Changes in PI were similar in femoropopliteal and
femorodistal grafts for any IPC mode. PI on IPCfoot+calf
was similar to that on IPCcalf . PI on IPCcalf and IPCfoot+calf
was lower than that on IPCfoot (both P = 0·004).
Discussion
This study has shown that IPC enhances flow through
infrainguinal arterial bypass grafts, irrespective of the level
of distal anastomosis. Flow was maximally increased in
both femoropopliteal and femorodistal autologous vein
grafts with IPCfoot+calf , followed by IPCcalf . IPCfoot was
the least effective mode investigated, but still augmented
flow significantly. Volume flow enhancement with any of
the IPC modes was associated with a significant increase
in mean flow velocity. In femoropopliteal grafts, volume
flow enhancement with IPCfoot+calf and IPCcalf was also
associated with a significant increase in luminal diameter.
This was noted in femorodistal grafts only on application of
IPCfoot+calf . The MV within 5 s of IPCfoot+calf application
was 236 per cent higher than baseline in femoropopliteal
and 179 per cent higher in femorodistal grafts.
All IPC modes produced a significant increase in
EDV, and an equivalent decrease in PI, indicating a
marked decrease in peripheral resistance13,14. A marker
of impedance in the distal vascular bed, PI increases with
vasoconstriction and decreases with vasodilatation15.
An increase in the arteriovenous pressure
gradient1,4,16–18 is the main mechanism behind calf inflow
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augmentation with IPC on sitting. IPC empties the deep
veins and, until arterial flow refills them, venous pressure
remains lower and the arteriovenous pressure gradient
higher, causing blood flow to increase1,4,16,17. However,
this mechanism alone cannot explain the magnitude of
flow augmentation noted in normal subjects and patients
with claudication3,18. Shear stress forces in the peripheral
circulation upon pressure gradient and flow enhancement
may promote release of endothelial factors, such as
nitric oxide1,2,18, whose vasodilatory activity on resistance
arterioles should accentuate flow further2,18,19. Another
mechanism enabling IPC to reduce arterial resistance
involves the autoregulatory reflexes4. As veins empty, and
formost deflation time (16 s), venous pressure falls to below
25 mmHg16,17 . The venoarteriolar and myogenic reflexes
are suspended, causing peripheral resistance to fall20–23.
The greater flow enhancement with IPCfoot+calf is linked
to its superior venous haemodynamic performance16.
Low flow velocities and graft surface thrombogenicity
play cardinal roles in the pathophysiology of infrainguinal
bypass graft failure. Bandyk et al.12 demonstrated that
a PSV lower than 40 cm/s in autologous infrainguinal
grafts, compounded by low diastolic forward flow,
increased the risk of graft thrombosis. A peroperative
increase in coagulation factors, increased platelet reactivity
and release of tissue thromboplastin in blood enhance
thrombogenicity24. Low graft flow velocities in this
environment can trigger platelet activation, secretion and
aggregation, with subsequent thrombus formation and
graft occlusion25.
After infrainguinal graft insertion, hyperaemia develops
upon perfusion, followed by an increase in outflow
resistance26. EDV decreases and PI increases with
reactivation of the capillary autoregulatory mechanisms in
the distal circulation.With increasing peripheral resistance
in this phase, flow velocities may decrease below a
thrombotic threshold level11. Postoperative differences
in peripheral resistance are increasingly perceived to
affect the outcome of infrainguinal bypass grafting26,27.
Revascularization under the combination of general and
epidural anaesthesia appears to offer better graft patency
than that carried out under general anaesthesia alone26,27.
This may be the result of peripheral resistance reduction
by epidural anaesthesia26,27.
In the light of its haemodynamic effects, IPC offers
the potential to prevent velocity attenuation after surgery.
There is only a limited number of methods for enhancing
flow in infrainguinal grafts. By inducing peripheral
vasodilatation, prostaglandins cause a significant increase
in graft blood flow28. Iloprost, a synthetic analogue of
prostacyclin, generates a short-lived (20 min) decrease
in peripheral resistance and a 52 per cent increase in
graft flow when infused into femorodistal grafts before
perfusion29. In a multicentre randomized trial, however,
graft patency was not improved after 1 year of follow-up29.
IPC has no notable side-effects. The median volume flow
increase with IPC ranged from 76 per cent with IPCfoot,
for femoropopliteal and femorodistal grafts respectively, to
182 and 236 per cent with IPCfoot+calf .
Application of IPC has certain limitations. Deep vein
thrombosis and leg infection are contraindications, the
flow increase wanes soon after IPC is stopped, and effective
IPC use presupposes limb vein priming and thus limb
dependency. Furthermore, IPC should not be applied
directly to the anastomosis and surgical wounds after
bypass grafting as this might compromise tissue healing.
Different pneumatic cuffs andmodes increase the flexibility
of IPC: IPCfoot+calf can be used in femoropopliteal grafts,
IPCfoot in femorocrural grafts, and IPCcalf with narrow
cuffs in femoropopliteal or femoropedal grafts. When the
saphenous vein is harvested, long skin bridges improve
the applicability of IPC. Provided that early ambulation is
not unduly deferred, IPC may be used for intervals equal
to those of sequential compression implemented for deep
vein thrombosis prophylaxis.
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Integrity of venoarteriolar reflex determines level
of microvascular skin flow enhancement with
intermittent pneumatic compression
Marc Husmann, MD,a,b Torsten Willenberg, MD,a Hak Hong Keo, MD,a Silviana Spring, MD,b
Evi Kalodiki, MD, PhD,d and Kostas T. Delis, MSc, MD, MS, PhD,c Bern, and Zurich, Switzerland; and
London, United Kingdom
Objective: To investigate whether intermittent pneumatic compression (IPC) augments skin blood flow through transient
suspension of local vasoregulation, the veno-arteriolar response (VAR), in healthy controls and in patients with
peripheral arterial disease (PAD).
Methods: Nineteen healthy limbs and twenty-two limbs with PAD were examined. To assess VAR, skin blood flow (SBF)
was measured using laser Doppler fluxmetry in the horizontal and sitting positions and was defined as percentage change
with postural alteration [(horizontal SBF  sitting SBF)/horizontal SBF  100]. On IPC application to the foot, the
calf, or both, SBF was measured with laser Doppler fluxmetry, the probe being attached to the pulp of the big toe.
Results: Baseline VAR was higher in the controls 63.8  6.4% than in patients with PAD (31.7  13.4%, P  .0162). In
both groups SBF was significantly higher with IPC than at rest (P < .0001). A higher percentage increase with IPC was
demonstrated in the controls (242  85% to 788  318%) than in subjects with PAD, for each one of the three different
IPC modes investigated (98  33% to 275  72%) with IPC was demonstrated. The SBF enhancement with IPC
correlated with VAR for all three compression modes (r  0.58, P  .002 for calf compression, r  0.65, P < .0001 for
foot compression alone, and r  0.64, P  .0002 for combined foot and calf compression).
Conclusion: The integrity of the veno-arteriolar response correlates with the level of skin blood flow augmentation
generated with intermittent pneumatic compression, indicating that this may be associated with a transient suspension of
the autoregulatory vasoconstriction both in healthy controls and in patients with PAD. (J Vasc Surg 2008;48:1509-13.)Intermittent pneumatic compression (IPC) devices
have been used to improve lower limb perfusion.1-3 When
assessed by laser Doppler flowmetry or duplex ultrasound,
substantial increases in cutaneous and arterial blood flow
during IPC application have been reported.1,3-6 Different
mechanisms through which IPC induces a circulatory aug-
mentation have been discussed and studied. An undisputed
mechanism is the reduction of venous pressure in the
dependent foot by IPC, as blood is expelled from the foot
and calf to the thigh.7 This results in a greater arterio-
venous pressure gradient and hence augmentation of arte-
rial inflow. A putative mechanism is the transient suspen-
sion of local vasoregulation, the veno-arteriolar response
(VAR).8-12 In the sitting position, venous distension oc-
curs, eliciting a precapillary vasoconstriction, and hence a
decrease of capillary inflow. When blood is expelled from
the veins of the lower extremities, venous pressure de-
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Vascular Surgery.doi:10.1016/j.jvs.2008.07.016creases and the precapillary sphincter dilates. This reduc-
tion in resistance may result in elevated arterial inflow.
Previous studies have shown that the VAR in patients with
peripheral arterial obstructive disease (PAD) is impaired,
possibly as an adaptive response to a lower arterial perfusion
and pressure.9,11,13,14 Assuming that IPC produces blood
flow increase by temporarily abolishing postural vasocon-
striction, the effect of IPC might depend at least in part on
the VAR. We hypothesized that the integrity of postural
vasoregulation may correlate with blood flow augmenta-
tion on IPC application.
MATERIALS AND METHODS
Study groups. The effects of IPC on foot skin blood
flux were evaluated in 19 limbs of 15 healthy volunteers
(controls) and in 22 limbs of 14 patients with intermittent
claudication due to PAD.
Inclusion and exclusion criteria. All studied subjects
underwent clinical examination and lower limb arterial and
venous investigation that entailed duplex scanning and deter-
mination of ankle-brachial pressure indices (ABI) at rest and
after exercise challenge on a treadmill. ABIwas determined by
dividing the higher ankle pressure (obtained from the dorsalis
pedis or posterior tibial arteries) by the higher of the two
brachial artery pressures after a 15-minute resting period and
immediately after treadmill exercise challenge (3.8 km/h, 10%
gradient, one minute) for the resting and post-exercise pres-
sure indices, respectively. PAD patients had a long-term his-
tory of intermittent claudication ( two years and Rutherford
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after exercise (0.9). Duplex ultrasonography documented
infrainguinal arterial obstruction invariably pertaining to the
superficial femoral. Patients with significant aortoiliac disease
on duplex scan (50%diameter stenosis) were excluded. Peak
systolic velocity ratios 2.0 were used to account for (in the
superficial femoral artery) or exclude (in the aortoiliac arterial
segment) 50% or more luminal diameter stenosis.15,16 Exclu-
sion criteria included chronic venous disease (CEAP  2),
diabetes mellitus, sensory neuropathy (clinically), previous
lumbar sympathectomy, critical limb ischemia, gangrene/
ulcerations and use of vasoactive drugs. There were no signif-
icant differences between the age- and gender-matched con-
trols and patients with PADwith regard to cardiovascular risk
factors (Table).
Examination and scanning protocol. Subjects were
asked to withhold caffeine and nicotine for 12 hours prior
to skin blood flow assessment. To assess peripheral postural
vasoregulation, the veno-arteriolar response (VAR) was
measured by determining skin blood flow (SBF) using laser
Doppler fluxmetry in the horizontal and sitting positions
prior to IPC application. The VAR was calculated as (SBF
horizontal  SBF sitting)/SBF horizontal  100 (per-
cent). Afterward, all subjects were studied in the sitting
position on a high examination couch, with their feet
resting hanging off the floor. Foot and calf pads (cuffs) of
the IPC system were applied gently, and a resting period of
more than 20 minutes was allowed for flow stabilization,
during which all subjects remained comfortably seated. IPC
was then applied and skin flux measurements obtained,
starting from the fifth minute of pump action. Subse-
quently, the IPC was switched off and the subjects were
rested for more than 10 minutes, after which new resting
skin flux estimations were obtained. The same protocol was
followed to evaluate skin flux prior to and during delivery of
the last IPC mode examined.
Skin blood flux/flow was obtained using Laserflo BPM
403 (Vasamedics, St. Paul, Minn) featuring a semiconduc-
tor gallium-aluminium-arsenide diode emitting a laser
Table. Baseline characteristics of controls and patients
with stable claudication
Controls PAD
Age (years)a 70 (65-83) 71 (61-84)
Gender ratio (M:F) 10:5 10:4
Risk factors, n (%)
Smoking 8 (60) 9 (64)
Hypertensionb 6 (40) 9 (64)
High cholesterolc 6 (40) 8 (57)
Ankle: brachial pressure
indexa 1.05 (1.02-1.10) 0.71 (0.52-0.85)
aValues are mean (range).
bIncludes subjects on medications with normalized blood measurements at
the time of investigation.
cTotal cholesterol level 240 mg/dL/ low-density lipoprotein level 160
mg/dL/ high-density lipoproteine (40mg/dL)/ antilipemic medication.beam with a wavelength of 780 nm. The single pointvertical angle laser probe was attached to the pulp of the big
toe. The emittedmonochromatic coherent light of the laser
Doppler illuminates a tissue hemisphere with a radius of 0.1
to 1.4 mm interacting with the moving blood cells, and a
proportion of them produce back-scattering and a frac-
tional frequency shift, which is converted to skin blood flux
readings. The mean skin blood flux was estimated by ana-
lyzing five-minute laser Doppler fluxmetry recordings on a
thermosensitive strip obtained at a speed of 20 mm/min, a
sensitivity of 10 to 100, and an average time of five seconds.
Every effort was made to ensure good, consistent attach-
ment of the probe to the skin with minimal motion arti-
facts. Tracings thought to result from suboptimal probe
attachment were discarded, and measurements were re-
peated. All investigations were conducted in a noise-free,
temperature-controlled environment (21°-23°C) under
optimal resting conditions.
Impulse unit. Intermittent pneumatic limb compres-
sion was delivered with the Art Assist 1000 unit (ACI
Medical, San Marcos, Calif). This is a mechanical pneu-
matic pump built around a pneumatic impulse generator
which consists of an electrically driven air compressor and
an air reservoir venting intermittently into two inflatable
plastic pads designed to fit the foot and calf. One large-bore
elastic tube connects the unit with each one of the pads.
Investigation throughout the study was conducted with the
pump operating at the following preset parameters: maxi-
mum inflation pressure 120 mmHg, minimum deflation
pressure 0 mmHg; inflation rise time 0.3 seconds and
inflation time four seconds followed by 16 seconds of
deflation (0 mmHg), resulting in three compression cycles
min-1. Laser Doppler readings were obtained within the 16
seconds of pressure release over a total time period of five
minutes of IPC application.
Statistics. Values are shown as mean SEM. Analysis
was performed using nonparametric statistics on StatView
4.57 (Abacus Concepts, Berkeley, Calif). For intra-group
comparison of the effects of different modalities of IPC, the
Friedman test was used. For inter-group comparison, the
Mann-Whitney U test was applied. The Spearman rank
correlation was used to calculate the relation between VAR
and skin blood flow augmentation on IPC.
RESULTS
Skin blood flow (SBF) in the horizontal position was
similar between controls and PAD (6.8  2.8 to 7.1  1.5
arbitrary units, P  .68), whereas SBF in the sitting position
was significantly lower in the controls (2.1 0.8 vs. 5.3 1.6
arbitrary units, P  .01) (Fig 1). This resulted in a greater
VAR in the controls (63.8  6.4%) vs the PAD patients
(31.7 13.4%) (P .02) (Fig 2). All threemodes of pressure
application produced higher levels of SBF compared with the
resting values in both groups (P .0001). The percentage of
SBF increase on IPC was lowest with calf compression alone
(242 85% in controls and9833% inPADpatients) (Fig3).
Higher levels of SBF percentage increase were achieved in
the control group with foot compression and combined
foot and calf compression (697  205% and 788  318%
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or with combined foot and calf compression, the percent-
age increases were 275  72% and 230  57% respectively
(Fig 3). SBF with calf, foot, and combined foot and calf
compression were significantly higher in the controls com-
pared with PAD patients (P  .005, P  .0158, and P 
Fig 1. Pedal skin blood flow in recumbent and dependent posi-
tion in controls and patients with peripheral arterial disease.
Fig 2. Veno-arteriolar response in controls and patients with
peripheral arterial disease.
Fig 3. Percentage skin blood flow increase on intermittent pneu-
matic compression applied to the foot, the calf or both in healthy
controls and claudicants..006).There was a significant correlation between the VAR
and the SBF augmentation (percentage SBF increase) with
all three IPC modes when the controls and the PAD
patients were grouped together: r 0.58, P .002 for calf
Fig 4. Spearman correlations between veno-arteriolar response
and skin blood flux augmentation (percentage increase) with in-
termittent pneumatic compression applied to (a) the calf (r 0.58,
P .002), (b) the foot (r  0.65, P  .0001 ), or (c) foot and calf
(r  0.64, P  .0002), both in healthy controls and claudicants.compression (Fig 4, a), r  0.65, P  .0001 for foot
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and calf compression (Fig 4, c). When analysis was per-
formed for the PAD patients only, the VAR correlated well
with SBF augmentation on foot (r  0.69, P  .002) and
foot and calf (r  0.65, P  .0035) compression, but not
on calf compression alone (r  0.36, P  .105). In the
control subjects, there was a correlation between the VAR
and the augmentation of SBF with IPC, when delivered to
the foot (r  0.55, P .017) and the calf (r  0.58, P 
.012), but not when delivered to foot and calf combined (r
 0.45, P  0.15).
DISCUSSION
The study data show that the greater the magnitude of
the veno-arteriolar response (VAR) the higher the percent-
age increase in skin blood flow with IPC, suggesting that a
transient attenuation of the VAR during IPC application
might be one of the mechanisms through which the latter
generates higher levels of blood flow in the lower limb.
Impairment of peripheral sympathetic postural auto-
vasoregulation, the local veno-arteriolar response, has been
documented in diabetes mellitus, diabetic and alcoholic
neuropathy, as well as in PAD.8,9,13,14 Recent work has
shown that the VAR becomes increasingly impaired with
PAD progression but is regained after successful bypass
grafting or endovascular treatment, suggesting re-ad-
justment of peripheral resistance.9,17,18 Improved arterial
leg inflow after bypass grafting or endovascular angioplasty
is associated with a reversal of peripheral vasodilatation and
a decrease in both arterial calf inflow and skin flux on
dependency.17,18 Our data is in accordance with previous
studies demonstrating an impaired VAR in patients with
intermittent claudication due to PAD.9,17,19
In keeping with previous reports, we also found lower
levels of skin blood flow augmentation with IPC in patients
with PAD than in healthy controls.1,4,20-22 Different physio-
logic mechanisms through which IPC induces its flow aug-
mentation effects have beenproposed.As previously noted, by
expelling the blood from the dependent leg, IPC increases the
arterio-venous pressure gradient generating arterial inflow
augmentation.6,7 The increased arterio-venous pressure gra-
dient, however, cannot explain by itself the high level of flow
augmentation with IPC observed both in normal limbs and
limbs with PAD. A decrease in peripheral resistance has been
reported, but the physiologic mechanism involved is not fully
understood.1,3 Increase in the arterio-venous pressure gradi-
ent results in release of vasodilatory endothelium-dependent
factors in response to shear stress, either by way of increased
arterial leg inflow and/or by the transmitted compression
impulses.23,24 Recent work has demonstrated 2- to 2.5-fold
up regulation of the endothelial nitric oxide synthase in un-
compressed upstream muscle secondary to IPC and its sup-
pression by nitric oxide synthase inhibitor one hour after
IPC.23
As venous pressure decreases to 25 mmHg or less during
most of the deflation time (16 seconds), it could be hypoth-
esized that the veno-arteriolar reflex during the application of
IPC is transiently suspended, with subsequent attenuation ofperipheral resistance.14,25 Our findings suggest that transient
suspension of the precapillary vasoconstriction (VAR) is one
of the mechanisms by which blood flow would improve with
IPC. Additionally, we could demonstrate that a higher skin
blood flow on application of IPC is obtained in limbs with
more pronounced and hence larger veno-arteriolar responses
as shown by a significant correlation between the VAR and
skin blood flow augmentation with IPC. In the dependent
limb, precapillary vasoconstriction induced by an increase in
venous pressure is a physiological mechanism to regulate the
hydrostatic arterial pressure augmentation offering protection
to the capillary bed. Precapillary vasoconstriction increases
peripheral resistance resulting in a lower skin blood flow on
dependency. Skin blood flow is lower in healthy limbs than in
limbs with PAD in the depending position, as shown in our
study and other previous reports.17,18,26 Therefore, the
higher percentage increase in SBF with IPC among healthy
limbs mirrors a greater vasodilatory capacity secondary to a
stronger vasoconstrictory status in the resting dependent
limb. Owing to arterial obstruction at the femoro-popliteal
segment and hence the reduced pressure in the distal arteries,
the lower VAR is a physiological vascular adaptation in
PAD.9,11
The present study enhances our insight into these perti-
nent physiologic mechanisms. Understanding the mecha-
nisms involved in blood flow augmentation with IPC is im-
portant for its clinical application. In patients with other
disorders that impair VAR (ie, diabetes or chronic venous
disorders), the flow enhancing mechanisms of IPC might be
different or have a modified effect.8,27,28 In addition, our
understanding of the mechanisms through which IPC en-
hances blood flow might increase its use, particularly as a
recent study has shown an improved limb salvage rate attrib-
utable to the use of IPC in patients with critical limb isch-
emia.2 With a growing elderly population and an increase in
metabolic syndrome, the prevalence of PAD will rise.29 Dif-
ferent therapeutic modalities are needed to treat patients with
limb ischemia. Parallel to surgical and endovascular interven-
tions, there is a need for additional conservative therapeutic
measures.30,31 Further studies need to investigatewhether the
combination of revascularisation and IPC improves the man-
agement of PAD patients. Current knowledge suggests that
shear stress and nitric oxide are crucial for angiogenesis.32-34
In patientswith impairedwalkingdistance or even critical limb
ischemia, peak shear stress is poor owing to proximal arterial
obstruction. Therefore, the application of IPC with a view to
enhancing shear stress and arterial leg inflow augmentation
might promote angiogenesis.
Limitations of the present study include the small pop-
ulation examined. Also, we evaluated only patients with
intermittant claudication, and these data are not directly
applicable to patients with critical limb ischemia as the VAR
is abolished.13,14 Because we excluded patients with diabe-
tes mellitus knowing that this disease itself might impair
VAR, the relation between VAR and blood flow augmen-
tation by IPC in such patients remains unclear.
In conclusion, skin blood flow augmentation with IPC is
associated with a transient suspension of the veno-arteriolar
JOURNAL OF VASCULAR SURGERY
Volume 48, Number 6 Husmann et al 1513vasoconstriction of the precapillary sphincter. In support of
prior pertinent data, this study reinforces the potential of IPC
to emerge as an important mechanical device enhancing skin
microcirculation in PAD.
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Long-term effects of endovascular angioplasty on
orthostatic vasocutaneous autoregulation in
patients with peripheral atherosclerosis
Marc J. Husmann, MD,a,b Matthias Barton, MD,c Vincenzo Jacomella, MD,a Antonio Silvestro, MD,a
and Beatrice R. Amann-Vesti, MD,b Berne and Zurich, Switzerland
Objective: To test the hypothesis that endovascular revascularization of femoropopliteal lesions improves the impaired
venoarteriolar response (VAR) in patients with atherosclerosis.
Methods: We prospectively compared VARs in 15 healthy controls (18 legs) and 14 patients (17 legs) with mild to
moderate peripheral arterial disease before and after successful peripheral endovascular angioplasty of femoropopliteal
lesions. In all subjects, foot skin blood flow was assessed by laser Doppler flowmetry in the horizontal (HBF) and sitting
(SBF) positions. VAR was calculated as (HBF  SBF)/HBF  100.
Results: In patients with peripheral arterial disease, mean HBF (in arbitrary units [AU]; mean  SD) was similar before
(25.6  15.3 AU) and after (27.0  16.4 AU) angioplasty (P  .67), whereas SBF was significantly lower after than
before the endovascular procedure (11.6  7.7 AU to 18.4  14.1 AU; P < .05). Intragroup differences between SBF
and HBF were significant before and after angioplasty (P < .001). VAR was higher after angioplasty (55.1%  21.2%)
compared with VAR before intervention (33.4%  20.2%; P  .015). Although VAR increased after the intervention,
VAR was still lower than in healthy controls (68.4%  20.5%; P  .025). During the 6 months of follow-up, the
ankle-brachial index and VAR remained unchanged (P > .05).
Conclusions: Patients with mild to moderate peripheral arterial disease have an impaired orthostatic autoregulation that
improves after successful endovascular revascularization of femoropopliteal obstructive lesions. The effect on VAR is
sustained in the absence of restenosis. ( J Vasc Surg 2006;44:993-7.)The autonomic nervous system regulates postural va-
soregulation, which is mediated through a sympathetic
axon reflex that acts on cutaneous, subcutaneous, and
muscular arterioles.1-4 A postural change from the horizon-
tal to the recumbent or upright position increases venous
pressure and elicits precapillary vasoconstriction, known as
the venoarteriolar response (VAR). The VAR is thought to
play a protective role in vascular homeostasis by preventing
the capillary bed from a sudden increase in pressure and
filtration.5-8
Different conditions such as chronic venous insufficien-
cy,5 diabetic autonomic neuropathy,6 administration of
calcium antagonists,7 and aging8 impair VAR. Severe dys-
function of the VAR occurs in peripheral arterial disease
(PAD) with either stable claudication or critical limb isch-
emia.9,10
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doi:10.1016/j.jvs.2006.06.038Skin blood flow, which is reduced in the feet of healthy
individuals in the sitting position when compared with the
horizontal position, is higher in the dependent position in
patients with obstructive arterial disease than in healthy
controls.11,12 In the presence of PAD, the VAR is attenu-
ated.9,10 Because of an impaired VAR, many PAD patients
with severely limited arterial inflow show skin redness on
dependency, which reflects a higher skin blood flow.10
Although contradictory results have been published about
VAR in patients with stable claudication,1,2,13 a recent
study demonstrated that successful surgical revasculariza-
tion causes short-term improvement of VAR in patients
with subcritical or critical lower limb ischemia.14 Whether
this is also applies for patients with mild to moderate
peripheral atherosclerosis, whether percutaneous endovas-
cular revascularization affects VAR, and whether revascu-
larization has long-term effects on VAR are unknown.
METHODS
Human subjects. This was a cohort study conducted in
a tertiary referral university hospital consisting of two groups.
Fourteen consecutive patients (17 legs investigated) were
included with stable intermittent claudication (Rutherford
stages I to III) caused by superficial femoral or popliteal
artery obstructions who were scheduled for elective endo-
vascular angioplasty and who met the inclusion criteria.
Fifteen healthy subjects (18 legs investigated) without PAD
or venous or lymphatic disease were recruited through
advertisements. The institutional ethics committee ap-
proved the study. The inclusion and exclusion criteria are
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II. Control subjects were recruited to match the patients for
age and sex. The prevalence of risk factors was significantly
different between patients and controls. All subjects were
asked to refrain from caffeine-containing drinks and smok-
ing for at least 12 hours before the investigation. Risk
factors in each group and ankle-brachial pressure indices
(ABIs) are presented in Table II.
All subjects underwent the following examination pro-
tocol. (1) A full medical history was taken, and a physical
examination was performed. (2) Venous color duplex im-
aging was used to detect chronic venous insufficiency as
described previously.15 (3) In patients, angiography was
performed before and after angioplasty. (4) Control duplex
imaging was used to evaluate femoropopliteal patency after
revascularization.16 (5) Laser Doppler fluxmetry was per-
formed to determine skin blood flow in the horizontal
(HBF) and recumbent positions (Laserflo BPM403; Va-
samedics, St Paul, Minn). The probe was secured at the
tip of the big toe by using ring-shaped double-sided
adhesive tape. Measurements of skin blood flow were
made after a 20-minute resting period in a temperature-
Table I. Inclusion and exclusion criteria
Inclusion criteria
No clinical symptoms or signs of peripheral arterial disease
(control)
Ankle-brachial index exceeding 0.9 (control group)
Initial claudication distance 100-300 m (claudication group
before angioplasty)
Successful angioplasty (on angiogram and duplex sonography;
claudication group)
Exclusion criteria
Evidence of sensory neuropathy/diabetes mellitus
Use of vasoactive medications
Chronic venous insufficiency
Previous lumbar sympathectomy
Critical limb ischemia
Gangrene/ulcerations
Table II. Demographic details
Variable
Controls
(n  15)
Claudication
(n  14)
Age (y)* 70 (65-83) 71 (61-84)
Sex ratio (M:F) 10:5 10:4
Risk factors
Smoking† 8 (6) 9 (4)
Hypertension‡ 6 9
High cholesterol 6 8
Ankle-brachial pressure
index* 1.05 (1.02-1.10) 0.71 (0.52-0.85)§
After angioplasty 0.89 (0.72-1.10)
*Values are mean (range).
†Values in parentheses are numbers of active smokers at the time of investi-
gation.
‡Includes subjects on medications with normalized blood measurements at
the time of investigation.
§Claudicants before angioplasty.controlled room (21°C-22°C). The recorded chart wasset at 20 mm/min (Brush 2600S Recorder; Gould,
Cleveland, Ohio).
Measurements of resting skin HBF were averaged over
10 minutes and expressed in arbitrary flow units (AU). The
subjects were then placed in the upright sitting position
with their feet in a stable dependent position. The probe
remained fixed at the tip of the big toe. Sitting blood flow
(SBF) was calculated during the 10 minutes after the initial
10 minutes of sitting to allow for stabilization of the skin
blood flow. The VAR was calculated as (HBF  SBF)/
HBF  100. Laser Doppler fluxmetry enables noninvasive
measurement of cutaneous blood flow and its changes
arising from alteration of posture.10,14 Red blood cell flow
is proportional to the concentration and velocity of red
blood cells flowing in the capillaries. These variables are
influenced significantly by the density of capillaries, known
to vary in the skin, affecting the spatial and temporal
variability of red blood cell flow measurements. By obtain-
ing red blood cell flow from the same position on the foot
during a single examination setting and expressing the
results as ratio flow values, the VAR can be estimated
reproducibly because differences in the temporal and spatial
domains are nullified.14
Statistics. Results are presented as means  SD. Sta-
tistical analyses were performed with StatView 4.57 (Aba-
cus Concepts, Inc, Berkley, Calif ). Data obtained from
different positions were compared by using the Wilcoxon
signed rank test. Intergroup (controls vs PAD) compari-
sons were performed with the Mann-Whitney U test.
Spearman rank correlation was used to analyze a correlation
between ABI and VAR. P .05 was considered significant.
RESULTS
In both patients and healthy controls, the skinHBFwas
significantly higher than SBF. Controls had lower skin blood
flow in both positions compared with PAD patients before
intervention (HBF: 7.0  2.9 AU vs 25.6  15.3 AU, P 
.001; SBF: 2.1  0.8 AU vs 18.4  14.4 AU, P  .001).
Similarly, decreases in skin blood flux on sitting (VAR)
were significantly higher in controls (68.4% 20.5%) than
in PAD patients before angioplasty (33.4%  20.2%; P 
.001).
In the PAD group, percutaneous revascularization did
not affect HBF (27.0 16.4 AU; P .56) but significantly
decreased SBF (11.6  7.7 AU; P  .001). Although
angioplasty resulted in a significant decrease in skin SBF,
the VARwas still lower in the PAD group (55.1% 21.2%)
than in controls (68.4%  20.5%; P  .05; Figs 1 and 2).
During follow-up, the PAD group showed a nonsignif-
icant tendency toward higher levels of both HBF (32.7 
23.7 AU) and SBF (17.8 8.7 AU) after 3 months and at
6 months (HBF, 35.6  19.2 AU; SBF, 17.2  10.9 AU;
P  .05). However, VAR remained unchanged during the
follow-up, at 55.7%  18.2% and 52.6%  18.3% after
3 and 6 months, respectively (P  .56; Fig 3). Similarly,
ABI did not change during the 6 months (0.92  0.21 at
3 months and 0.88  0.18 at 6 months; P  .67; Fig 4).
ABI decreased in five limbs of four patients, but none of
JOURNAL OF VASCULAR SURGERY
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quired percutaneous intervention. There was no correla-
tion between the changes in VAR and ABI (r  0.18; P
 .46).
DISCUSSION
The peripheral vasoregulatory response to orthostasis is
attenuated in patients with critical leg ischemia.1,4,10,17
However, the data available until now on autonomic func-
tion of patients with moderate PAD have been contradic-
tory.1,2,10,13 A recent study showed improvement of this
response in PAD patients after successful surgical infrain-
guinal bypass grafting within 7 days after surgery.14 We
now report that endovascular reconstruction of femoro-
popliteal lesions in patients with noncritical PAD improves
the VAR and that this beneficial effect is sustained during a
follow-up period of 6 months.
First described by Gaskell and Burton18 and later de-
scribed by Henriksen, Paaske, and associates,1,2,4 the VAR
is due to a local axon reflex on the arterioles in response to
passive venous distension. The result is an increase in periph-
eral resistance and a decrease in blood flow.6,7 This vasocon-
strictive response preserves systemic blood pressure in differ-
ent postures and prevents capillary pressure increases,
interstitial fluid leakage, and edema formation.1,2,4,6,7 La-
ser Doppler flow measurements have been established as a
noninvasive method for the investigation of microcircula-
tory flow in health and disease. As red blood cell flow at the
same position in the supine and sitting positions is mea-
sured, temporal and spatial variability are nullified. This
method allows reproducible testing of vascular microcircu-
latory function and dysfunction.5,9,10,19
This study demonstrates that patients with noncritical
PAD with stable intermittent claudication due to femoro-
popliteal obstructions have a significantly greater flux in the
dependent position than healthy age- and sex-matched
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Fig 1. Effect of angioplasty on skin blood flow and vasocutane-
ous autoregulation. Skin blood flow in supine (Flux supine) and
sitting (Flux sitting) position and the decrease in flux on sitting
(venoarteriolar response; VAR) in patients with stable intermittent
claudication. Measurements were obtained before and after suc-
cessful percutaneous angioplasty of femoro-popliteal obstructions.
*P  .05 before versus after angioplasty.subjects. This indicates that vasocutaneous autoregulationis already impaired at an early stage of peripheral vascular
disease because of either local neurologic damage and/or
physiological resetting of arterioles, possibly to optimize
perfusion in the ischemic leg.
A previous short-term study demonstrated that auto-
regulation returns to normal within 7 days after infraingui-
nal bypass surgery performed for noncritical limb isch-
emia.14 Because nerve tissue repair requires much longer
(up to several months), it seems likely that the mechanisms
involved require a physiological resetting rather than nerve
regeneration. In this study, there was no further improve-
ment of autoregulation between the first and sixth months
after successful revascularization. This supports previous
findings that local vasoregulation is pressure and/or flow
sensitive to maintain local tissue perfusion.14
The results of our study have possible clinical implica-
tions. The measurements of skin blood flow by laser Dopp-
ler fluxmetry before or after an intervention or during
follow-up may provide additional information about the
degree of improvement of vascular autoregulation in pa-
tients with noncritical limb ischemia. The findings of this
study may also help us to understand the acute and chronic
pathophysiological mechanisms involved in cutaneous va-
soregulation. Our study, for the first time, to our knowl-
edge, shows a long-term beneficial effect of percutaneous
transluminal interventions on peripheral vasoregulation of
the lower limb. Additionally, VAR may reflect the func-
tional reserve capacity, which has been proposed as one
mechanism through which intermittent pneumatic com-
pression may improve peripheral arterial macrocirculation
and microcirculation in healthy controls and patients with
PAD.20-22 Indeed, intermittent pneumatic compression
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Fig 2. Vasocutaneous autoregulation in controls and in patients
with peripheral arterial disease. Decrease in skin blood flow on
sitting (venoarteriolar response; VAR) in healthy controls com-
pared to patients with stable intermittent claudication before and
after femoro-popliteal angioplasty. *P .05 versus controls; †P
.05 before versus after angioplasty.(of the lower limb) improved peripheral blood flow up to
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higher increases in healthy controls and patients after suc-
cessful infrainguinal bypass grafting.20-22 When compres-
sion in the dependent position empties the venous pooling,
the venoarteriolar reflex is attenuated,23 and local skin
perfusion increases via dilation of the precapillary sphincter.
Given the findings of this study, the combination of femo-
ropopliteal angioplasty and intermittent pneumatic com-
pression may have synergistic effects, which merits further
experimental and clinical studies.
This study is limited by the small number of patients
investigated and the fact that only patients with mild to
moderate PAD were included. However, VAR assessment
requires additional instruments and examination time, and
at present there is no indication to routinely perform VAR
measurement in addition to ABI measurements. The study
also did not include patients with diabetes, venous hyper-
tension, or critical limb ischemia so that we examined a
rather homogenous group to exclude confounding factors
that may impair VAR.5,10,13 Therefore, these findings are
likely to reflect a pathophysiological mechanism in patients
with only peripheral atherosclerosis.
In conclusion, patients with mild to moderate peripheral
atherosclerotic disease already exhibit impaired orthostatic
local autoregulation at a stage of noncritical limb ischemia.
Percutaneous angioplasty of femoropopliteal obstructions im-
proves peripheral vasoregulation, possibly through a flow-
and/or pressure-related mechanism. The observation that
the improvement in VAR is sustained 6 months after treat-
ment also suggests a possible long-lasting positive effect of
angioplasty on orthostatic autoregulation in the absence of
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Fig 3. Long term effect of angioplasty on vasocutaneous autoreg-
ulation in patients with peripheral arterial disease. Decrease in skin
blood flow on sitting (venoarteriolar response; VAR) in patients
with stable intermittent claudication before and six months after
femoro-popliteal angioplasty. *P  .05 for follow-up after angio-
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Successful lower extremity angioplasty improves
brachial artery flow-mediated dilation in patients
with peripheral arterial disease
Marc Husmann, MD,a,b Janine Dörffler-Melly, MD, PhD,a Christoph Kalka, MD,a Nicolas Diehm, MD,a
Iris Baumgartner, MD,a and Antonio Silvestro, MD,a Berne and Zurich, Switzerland
Introduction: Peripheral arterial disease (PAD) is associated with systemic impaired flow-mediated dilation (FMD) and
increased risk for cardiovascular events. Decreased FMD may be caused by a decrease in arterial shear stress due to
claudication and inflammation due to muscle ischemia and reperfusion. We assumed that endovascular revascularization
of lower limb arterial obstructions ameliorates FMD and lowers inflammation through improvement of peripheral
perfusion.
Methods: The study was a prospective, open, randomized, controlled, single-center follow-up evaluation assessing the
effect of endovascular revascularization on brachial artery reactivity (FMD) measured by ultrasound, white blood cell
(WBC) count, high-sensitive C-reactive protein (hs-CRP), and fibrinogen. We investigated 33 patients (23 men) with
chronic and stable PAD (Rutherford 2 to 3) due to femoropopliteal obstruction. Variables were assessed at baseline and
after 4 weeks in 17 patients (group A) who underwent endovascular revascularization and best medical treatment, and in
16 patients (group B) who received best medical treatment only.
Results: FMD did not differ between group A and B (4.96%  1.86% vs 4.60%  2.95%; P  .87) at baseline. It
significantly improved after revascularization in group A (6.44%  2.88%; P  .02) compared with group B at 4 weeks
of follow-up (4.53%  3.17%; P  .92), where it remained unchanged. The baseline ankle-brachial index (ABI) was
similar for group A and B (0.63 0.15 vs 0.66 0.10; P .36). At 4 weeks of follow-up, ABI was significantly increased
in group A (1.05  0.15; P  .0004) but remained unchanged in group B (0.62  0.1). WBC counts of the two groups
were comparable at baseline (group A: 7.6  2.26  106/mL and group B: 7.8  2.02  106/mL, P  .81). In group
A, the leukocyte count significantly decreased after angioplasty from 7.6 2.26 to 6.89 1.35 106/mL (P .03). For
group B, WBC count did not differ significantly compared with baseline (7.76  2.64  106/mL; P  .94). No effects
were observed on hs-CRP or fibrinogen from endovascular therapy.
Conclusion: Endovascular revascularization with reestablishment of peripheral arterial perfusion improves FMD and
reduces WBC count in patients with claudication. Revascularization may therefore have clinical implications beyond relief
of symptoms, for example, reducing oxidative stress caused by repeated muscle ischemia or increased shear stress due to
improved ambulatory activity. ( J Vasc Surg 2008;48:1211-6.)Peripheral arterial obstructive disease (PAOD) is a
common manifestation of atherosclerosis affecting 5% of
the aged population.1 Despite the low rate of peripheral
complications and amputation, PAOD is associated with a
minimal to severe impairment in functional activity and
with an increased risk of future cardiovascular events.2-5
For this reason, PAOD is considered a marker for systemic
atherosclerosis. To date the most powerful prognostic in-
dicator in PAOD patients is the ankle-brachial pressure
index (ABI).6
Recent data suggest that increased inflammatory activ-
ity and endothelial dysfunction could be linked in PAOD
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doi:10.1016/j.jvs.2008.06.039patients and affect cardiovascular outcomes.7,8 The degree
of elevation of white blood cell (WBC) count within the
normal range is a marker for increased risk for cardiovascu-
lar events in patients with PAOD.9,10 This had been attrib-
uted to repeated muscle ischemia producing oxidative
stress, with subsequent subclinical inflammatory activa-
tion.7,11-13 For example, treadmill exercise in these patients
is associated with a systemic inflammatory response14,15
and acute systemic endothelial dysfunction at distant
sites.12 Thus, the ischemia–reperfusion injury associated
with intermittent claudication could be among the causes
for increased inflammatory activity and endothelial dys-
function in PAOD patients.12,16,17
Claudication also results in decreased physical activity
and hence reduced shear stress.16 Repeated shear stress has
been shown to be one of the strongest stimuli for improve-
ment of endothelial function through an increase in nitric
oxide synthesis.17,18 The two factors, postischemic muscle
reperfusion and decreased shear stress, seem to be synergis-
tic causes for deterioration of endothelial function in
PAOD patients.
In recent years noninvasive ultrasound-based assess-
ment of brachial arterial flow-mediated dilatation
1211
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impairment (endothelial dysfunction) consisting in a
decreased ability of the artery to dilated upon augmented
blood flow after a transient forearm ischemia.19 Impaired
FMD is thought to be linked to nitric oxide availability in
the endothelium.20 In addition, a predictive value of
FMD for cardiovascular events in patients with PAOD
has been reported recently.8,21
The aim of this study was to prospectively assess
whether the correction of intermittent leg ischemia by
endovascular revascularization is associated with a reduc-
tion in inflammatory mediators and thus an improvement
in endothelial function.
METHODS
Study design. The study was conducted at a tertiary
referral center as a prospective, open, randomized, con-
trolled, single-center follow-up evaluation assessing the
effect of lower limb endovascular revascularization on en-
dothelial dysfunction and inflammatory indicators (plas-
matic procoagulant activity) in patients with symptomatic
PAOD. Only patients with chronic and stable PAOD
(Rutherford class 2 to 3) due to femoropopliteal obstruc-
tion were eligible for the study.22 Exclusion criteria were
history of lower limb or coronary revascularization, acute
ischemic event within the last 3 months, chronic inflamma-
tory disorders, moderate or severe renal insufficiency, and
severe liver disease. Patients with incompressible tibial ar-
teries and persistent claudication after angioplasty were not
eligible for the study.
Randomization for angioplasty (group A) or conserva-
tive treatment (group B) was accomplished by a procedure
that used a random numeric sequence. The investigators
who performed FMD and laboratory analyses were blinded
to patient treatment allocation. The local ethic committee
approved the study, and all patients gave written informed
consent.
Assessment of brachial artery FMD, WBC count, high-
sensitive C-reactive protein (hs-CRP), and fibrinogen were
performed at baseline and at 4 weeks after randomization in
both groups. Before the investigations, patients were at rest
overnight and were not allowed to consume nicotine, caf-
feine, or to take vasoactive drugs for at least 10 hours before
the experiments and blood sampling. Patients were not
exposed to any other study drug or therapeutic treatment.
Endovascular procedures. Assessment before and af-
ter the intervention included clinical examination, Doppler
measurements of lower limb occlusive pressures with calcu-
lation of the ankle-brachial index (ABI), color duplex
sonography, and determination of routine laboratory tests.
Endovascular treatment was performed in the routine
manner. A 4F to 6F sheath that was compatible with an
over the wire low-profile dilation balloon and, occasionally,
an additional stenting system, which was at the discretion of
the interventionalist, was introduced antegrade into the
common femoral artery of the affected leg. After sheath
placement and diagnostic angiography, 5000 U of unfrac-
tionated heparin was injected intra-arterially.Postinterventional therapy lasted 4 weeks and consisted
of aspirin (100 mg/d) or clopidogrel (75 mg/d), or both
in case of stent insertion. To exclude any medication effects
on the investigated indicators, medication remained un-
changed except for clopidogrel in case of stent implantation
(2 patients). This medication was initiated after baseline
assessment and angioplasty with stent implantation and
lasted for 28 days.
Follow-up visits were done at day 30 to 32 after the
intervention. Successful angioplasty was defined by a final
angiogram with residual stenosis of 30% and postinter-
ventional ABI improvement of at least 0.1. In addition,
pain free walking distance was proven the day after the
procedure and at 30 to 32 days later by treadmill testing.
Assessment of FMD. Ultrasound assessment of
endothelial-dependent FMD of the brachial artery was done
according to recently reported guidelines.23 The study was per-
formed between 8 and 10 AM in a temperature-controlled room
(20° to 22°C)with subjects resting in a supine position. Brachial
diameter was imaged using a high-resolution (14-MHz line
array) transducer ultrasound system (Siemens, Erlangen, Ger-
many) equipped with electronic callipers, vascular software for
two-dimensional imaging, color and spectralDoppler, and inter-
nal electrocardiogram.
The brachial artery was imaged at a location 2 to 5 cm
above the cubital fossa. A sphygmomanometer cuff was
placed on the forearm. The cuff was inflated at least 50 mm
Hg above systolic pressure to occlude artery inflow for 5
minutes. All vasodilation measurements were made at the
end of diastole. Off-line measurements were performed on
a personal computer using the brachial reactivity analysis
software (Siemens). The response of the vessel diameter to
reactive hyperemia was calculated and expressed as a per-
centage change relative to the diameter immediately before
cuff inflation. Off-line analysis was performed by one oper-
ator (A. S.) in a blinded fashion.
Assessment of ABI and treadmill testing. The ABI
was calculated with the patient supine. The highest systolic
pressure of the anterior or posterior tibial artery was mea-
sured in each limb and was divided by the highest brachial
artery pressure. Standardized treadmill testing was per-
formed at 3.2 km/h and 12% inclination, 1 day postproce-
dure and 4 days later, to assess 10 minutes of pain-free
walking time in patients after angioplasty.
Biochemistry. Measurement of hs-CRP was done
using an immunoturbidimetric detection method
(Roche, Hitachi Modular P800, Basel, Switzerland).
Fibrinogen clotting was measured according to the
Clauss method on a Behring BCS coagulation analyzer
using Multifibren U (Dade Behring Diagnostics, Sie-
mens Healthcare Diagnostics, Deerfield, Ill).24 Platelet
and WBC counts were measured by an LH-750 and
LH-780 System (Beckman-Coulter Inc, Fullerton, Calif)
and ADVIA 120 Hematology system (Siemens Health-
care Diagnostics). Enzymatic methods were used to
measure plasma total cholesterol and triglycerides
(Roche). Low-density lipoprotein cholesterol was calcu-
lated using the Friedewald formula.25
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standard deviation (SD). Data were analyzed using the
Mann-Whitney U test for intergroup comparison and the
Wilcoxon signed rank test for intragroup comparison. Sam-
ple size calculation was based on data by Brendle et al,26
who demonstrated an improvement of FMD by 61% (from
0.18  0.03 to 0.29  0.04 mm) after a 6-month walking
exercise therapy. Assuming an effect size of 1.61 ( 0.05;
power 0.80, two-tailed) we calculated a sample size of 16
subjects per group. Expecting a drop-out rate of 20%, we
had to evaluate 42 patients (21 per group). Data were
analyzed with StatView 5.0.1 software (Adept Scientific,
Acton, Mass). A value of P  .05 was considered to be
significant.
RESULTS
Patient demographics. Nine patients were excluded
from the study, four from group A because of persistent
claudication after endovascular revascularization and five in
group B due to cardiovascular events before the follow-up
assessment. For analysis of indicators, only patients with
complete baseline and follow-up assessment were included,
resulting in 17 patients (group A) with successful angio-
plasty and subsequently pain-free walking distance during
10 minutes on the treadmill, and 16 patients in group B
with best medical treatment. Clinical baseline characteris-
tics did not differ among PAOD patients of both groups
(Table I). Patients in whom endovascular therapy was not
successful were not included.
Flow-mediated dilation. FMD did not differ signifi-
Table I. Clinical characteristics of patients with
peripheral arterial obstructive disease in group A
(angioplasty) and group B (conservative treatment)
Variable
Group A
(n  17)
Group B
(n  16) P
Age, mean (range), years 66 (47-82) 72 (53-84) .25
Sex, No.
Males 11 6 .12
Females 6 10
Body mass index, kg/m2 26.2 26.8 .69
Hypertension, No. % 12 (71) 12 (75) .54
Diabetes mellitus, No. % 4 (24) 4 (25) .73
Dyslipidemia, No. % 9 (56) 11 (68) .10
Smoking, No. %
Active 8 (47) 8 (50)
Former 3 (18) 7 (44) .08
Never 6 (35) 1 (6)
Coronary artery disease, No. % 4 (23) 4 (25) .73
Cerebrovascular disease, No. % 3 (17) 0 (0) .10
Medication, No. %
Aspirin/clopidogrel 16 (94) 14 (87) .90
Oral anticoagulation 1 (6) 3 (13) .76
Statin 7 (41) 9 (56) .17
ACE inhibitor 7 (41) 6 (38) .89
Calcium antagonist 2 (11) 1 (6) .67
Angiotensin receptor
blocker 3 (17) 4 (25) .45
ACE, Angiotensin-converting enzyme.cantly between group A (4.96%  1.86%) and B (4.60% 2.95%) at baseline (P  .65). After successful endovascular
revascularization, FMD significantly increased in group
A compared with baseline (6.44%  2.88%; P  .02;
Fig 1). FMD of group B did not change during fol-
low-up (4.53%  3.17%; P  .92) and differed from
postinterventional FMD of group A, although this dif-
ference did not reach statistical significance (P  .09).
The ABI was similar for group A and B at baseline
(0.63  0.15 vs 0.66  0.10; P  .36). The ABI
significantly increased in group A after revascularization
(1.05  0.15; P  .0004) but remained unchanged in
group B at follow-up (0.62  0.1; P  .82).
Laboratory analysis. The WBC counts of the two
groups were comparable at baseline, at 7.6  2.26 
106/mL for group A and 7.8 2.02 106/mL for group
B (P .81; Fig 2). After angioplasty, a slight but significant
decrease occurred in the WBC count for group A (6.89 
1.35  106/mL, P  .03). For group B, WBC count did
not change significantly compared with baseline (7.76 
Fig 1. Endovascular revascularization in group A (black bars)
improved flow-mediated dilation compared with baseline (*P 
.02) and with group B (conservative treatment, white bars) at
follow-up (P  .09). Conservative treatment did not alter flow-
mediated dilation in group B (P  .92). Error bars show the
standard deviation.
Fig 2. Effect of angioplasty on white blood cell count on group A
(revascularization, black bars) and group B (conservative treat-
ment, white bars). Error bars show the standard deviation. *P 
.03 for group A compared with baseline.2.64  106/mL, P  .94). In contrast, there was no
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263  79  103/mL; group B, 225  85  103/mL) to
follow-up (group A, 260 85 103/mL; group B, 212
69  103/mL) or significant differences between the two
groups.
Although the levels of hs-CRP and fibrinogen were
slightly lower in both groups at follow-up, these differences
were not significant, nor did the values differ between the
groups at baseline or follow-up (Table II).
DISCUSSION
Patients with PAOD exhibit a marked deterioration of
FMD and increased levels of inflammatory and oxidative
stress markers, possibly due to the atherosclerotic burden,
muscle ischemia and reperfusion, and decreased shear stress
due to claudication.8,13,27-29 Furthermore, higher levels of
WBCs within the normal range were shown to be associ-
ated with poorer prognosis in PAOD patients.10,30 The
present study indicates that endovascular treatment of in-
termittent claudication ameliorates FMD and reduces
WBC count.
So far, a beneficial effect has only been shown for
antioxidative treatment in PAOD patients, which resulted
in a transient improvement of FMD.12,13,31 This is thought
to be due to the scavenging effects of antioxidants on
reactive oxygen species that result from reperfusion of
ischemic muscle. Successful revascularization attenuates
muscle ischemia and therefore generation of reactive oxy-
gen species and inflammation. Inflammation and free oxy-
gen radicals reduce nitric oxide bioavailability. The abolish-
ment of claudication and hence generation of reactive
oxygen species may partly explain our observation, because
FMD has been shown to closely correlate with nitric oxide
bioavailability.20
In addition, the limitation of physical activity by inter-
mittent claudication is relieved through successful endovas-
cular repair. Physical activity (ie, walking) has been shown
to be the main stimulus for endothelial-dependent vasodi-
Table II. Effect of angioplasty (group A) and
conservative treatment (group B) on high-sensitive
C-reactive protein and fibrinogen in patients with stable
symptomatic peripheral atherosclerotic disease
Indicator
Group A
(n  17) Pa
Group B
(n  16)
Fibrinogen (g/L)
Baseline 3.87  0.53 .48 4.24  0.69
Follow-up 3.54  0.54 .52 4.0  0.78
Pb .44 .41
Hs-CRP (mg/L)
Baseline 2.93  2.16 .46 2.67  1.12
Follow-up 2.39  1.46 .25 2.2  1.01
Pb .17 .28
Hs-CRP, High-sensitive C-reactive protein.
aIntergroup comparison.
bIntragroup comparison.latation through a rise in shear stress.32,33 An increase inendothelial nitric oxide synthesis is an important physio-
logic adaptation to regular exercise. Moreover, regular
exercise has been shown to improve vascular function in
adults independent of changes in other risk factors.34,35
Therefore, besides being of pathophysiologic interest, our
findings may also have a clinical application in that the
indication for endovascular treatment in patients with in-
termittent claudication may be expanded beyond simple
pain relief.
Epidemiologic studies have demonstrated a high prev-
alence of vascular events in patients with PAOD.3,36 Several
studies have clearly shown the importance of engaging in
regular exercise to attenuate or reverse the disease process
in patients with cardiovascular disease.37 Continuous walk-
ing, either three times for 60 minutes or six times for 30
minutes per week, had been proposed as being sufficient for
attenuation of atherosclerotic disease progression.38 It is
highly unlikely, however, that patients with PAOD and at
Rutherford stages 2 or 3 are able to walk for half an hour.
Studies on walking exercise in patients with PAOD dem-
onstrate an increase of up to 400% in pain-free walking
distance.39 This increasemay still be far beyond the capacity
to continuously walk for half an hour to provide a sufficient
stimulus for prolonged shear stress for sufficient effect on
nitric oxide synthesis.
In our study, endovascular therapy resulted in an in-
crease of walking capacity that was proven by treadmill
testing 4 weeks after the procedure. Increased physical
activity, although not quantified in our study, could explain
the changes found already after a 4-week follow-up. It is
well known that exercise training improves ambulatory
function collateralization, resulting in an improved pain-
free walking distance. The development of collateralization
is slow, however, whereas in contrast, successful angioplasty
reestablishes full walking capacity immediately. This facili-
tates physical activity.
Presently, it remains unclear whether the abolishment
of claudication and hence reduction in oxidative stress or
already increased physical activity explains a better FMD in
our study population. Provided the absence of additional
oxidative stress (ie, repeated muscle ischemia), it has been
shown that exercise affects FMD already after a short train-
ing time of 4 weeks.40
Other possible factors, such as vitamin supplementa-
tion or other medications with aspirin/clopidogrel, or
both, on FMD and WBC count are unlikely to have af-
fected the present findings because patients were asked to
continue their medication unchanged and to withhold any
supplementation. In two patients who had stent implanta-
tion, clopidogrel medication was ceased 2 to 4 days before
the follow-up assessment.
Findings of a reduced WBC count in our study may be
related to the abolishment of muscle ischemia after success-
ful revascularization. This is an important finding, because
the degree of elevation of WBC count within the normal
range is a marker for an increased risk of cardiovascular
events.10 In contrast, we did not find any changes in the
platelet count. Similarly, hs-CRP and fibrinogen remained
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due to reduction of inflammation might be expected. In
accordance with our findings of unchanged hs-CRP and
fibrinogen,Wahlgren et al41 reported a transient increase in
fibrinogen and hs-CRP levels within the first day after the
endovascular procedure, but these markers did not differ
from baseline values at the 1-month follow-up. The time
period in our study may have been too short, or the study
population too small, to reveal any beneficial effects of
increased physical activity or decreased oxidative stress, or
both, on hs-CRP and fibrinogen.
The lack of assessment of physical activity or markers of
oxidative stress is a shortcoming of the present study.
Future studies are needed to address these questions, both
in terms of pathophysiologic understanding and therapeu-
tic management of PAOD patients. Another limitation is
the lack of structured exercise training for both groups.
However, the extent of exercise training would then differ
with regard to absolute walking capacity between the two
groups, whereas the present scenario represents the real-
world setting. Nevertheless, the possible spontaneous in-
crease in physical activity, which is mainly attributable to
relief of symptoms in the angioplasty group, demonstrates
the importance of endovascular revascularization in terms
of freedom from pain that might be able to counteract a
sedentary lifestyle.
So far, the endovascular treatment for Rutherford
stages 2 to 3 was aimed to improve patients’ quality of life.
If PAOD is recognized as a restriction of physical activity in
a growing elderly population and endovascular or surgical
revascularization can be confirmed to increase physical
activity, thereby reducing cardiovascular morbidity and
mortality, additional systemic benefits of revascularization
in terms of public health economy may outweigh the initial
costs. Future randomized studies comparing conservative
vs endovascular therapy are warranted to confirm the
present findings in larger patient settings incorporating
cardiovascular end points.
In conclusion, endovascular revascularization for stable
claudication resulting in alleviation of symptoms improves
brachial artery endothelial function and decreases leukocyte
count.
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